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Polysaccharide nanoparticles: From fabrication to applications 
Alexander Plucinski,a,† Zan Lyu a,† and Bernhard V. K. J. Schmidt a,* 
Polysaccharides have attracted considerable attention in a broad range of applications in recent years, which is due to their 
remarkable features such as biocompatibility, biodegradability, renewable origin, and facile modification. Considerable 
research efforts have been focused on developing polysaccharide nanoparticles and to promote their applications in various 
areas and biomedicine in particular. The present review highlights the properties of common polysaccharides used in 
nanoparticle formation as well as strategies to fabricate polysaccharide nanoparticles. Furthermore, the combination of 
polysaccharide nanoparticles and polymers is presented and brought into the context of applications. Finally, applications 
of polysaccharide nanoparticles as nano-delivery system, Pickering emulsion stabilisers, and material reinforcing agent in 
the fields of nanomedicine, cosmetics, and food system are highlighted. Moreover, this review describes and critically 
discusses present limitations and drawbacks in the preparation and use of polysaccharide nanoparticles, revealing directions 
to develop polysaccharide nanoparticles for further utilisation in various applications in the future.
1. Introduction 
Hydrophilic polymers and water-based polymer systems have 
gained significant attention over the past decades due to their 
applications in various interdisciplinary areas e.g. drug-
delivery,1 tissue-engineering,2 catalysis,3 membrane 
technology,4 aggregate formation5, 6 or phase separations like 
aqueous two-phase systems (ATPS).7 Especially, nanoparticle 
(NP) based technology8 is a significant area in biomedical,9 
pharmaceutical,9 cosmetic/cosmeceutical10, 11 and food 
industry.12 As such, NPs have been prepared and utilised in the 
areas such as targeted substance delivery, emulsion 
stabilisation, imaging on the molecular scale for diagnostic 
applications, and material reinforcement.13-1516-18 Moreover, 
emulsion stabilisers based on NPs have been extensively 
studied for application as cosmetic formulations,19 in oil-in-
water (O/W) emulsions20, 21 and in water-in-water (W/W) 
emulsions.22, 23 The transformation of traditional food and 
agriculture sectors is also significantly promoted by 
nanotechnology. In addition to transporting bioactive 
substances like nutrients, numerous novel applications such as 
smart and active packaging, nanosensors, nanopesticides and 
nanofertilisers have been invented for improving food quality 
and agricultural output.12  
Polysaccharides are a significant class of hydrophilic polymers 
with natural origin and biocompatibility that find frequent use 
in water-based polymer systems and in nanotechnology in 
particular, which is mainly due to their favourable properties in 
biological systems, e.g. biodegradability, biocompatibility, and 
low-toxicity. These properties constitute considerable 
requirements for the utilisation of NPs and thus polysaccharides 
represent an ideal class of building blocks for NP fabrication.24 
For example, in the field of medical therapy, polysaccharide-
based NPs have the advantages of high loading efficiencies, fast 
drug release rates and good targeting ability as well as high 
stability and low toxicity in physiological environment.9, 25, 26 In 
addition to biodegradability and biocompatibility, 
polysaccharides have gained considerable attention due to their 
abundance, facile processing and sustainable feedstocks (refer 
to Section 2).19 The chemical functionalisation of 
polysaccharides is mainly achieved by using the free carboxyl 
and hydroxyl groups distributed along the backbone of the 
polysaccharides. The utilisation of these reactive groups allows 
the fabrication of suitable polysaccharide derivatives with 
determined properties (e.g. hydrophobicity, solubility), 
promoting further use of polysaccharides in specific application 
areas.25, 27, 28  
Scheme 1. Overview of polysaccharide NP formation and their applications. 
Based on common mechanisms such as ionic crosslinking, 
covalent crosslinking, self-assembly of hydrophobically 
modified polysaccharides, polyelectrolyte complexation, and 
forming polysaccharide–drug conjugates (refer to Section 3),25 
many researchers have designed different approaches to 
synthesise polysaccharide-based NPs with controlled size, 
morphology, and structure (Scheme 1).29 The key point of the 
choice of the synthetic route is to optimise the final properties 
of NPs designed for a specific application. In addition, a series 
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of factors such as physicochemical parameters of the 
polysaccharides used, polysaccharide chemical composition, 
NPs size, and surface morphology, can be used as a guide during 
the synthesis process.30 Sometimes, misunderstandings occur 
because of the misuse of the term NP referring to both NP and 
nanocrystal, which are indeed different types of materials. NPs 
are amorphous particles while nanocrystals are crystalline.31 
Therefore, polysaccharide nanocrystals will not be discussed 
detailly in the following sections, but some useful applications 
will be mentioned. 
As polysaccharide-based NPs have a broad range of possible 
applications, understanding the mechanism of action is highly 
important. In this review, the properties of several common 
polysaccharides (refer to Section 2) and practical methods for 
preparing their NPs will be discussed (refer to Section 3). Also, 
the development of polysaccharide/polymer NP systems (refer 
to Section 4) is discussed, highlighting the advantages of the NP 
system obtained from a polysaccharide and synthetic polymer 
combination. Finally, on the basis of the preceding sections, the 
emphasis of this review is to survey some useful applications of 
polysaccharide-based NPs in nanomedicine, cosmetics, and 
food (refer to Section 5). At last, we will summarise the 
developments in the field of polysaccharide NPs and give an 
outlook for future directions. 
2. Polysaccharides 
Polysaccharides are natural polymers consisting of 
monosaccharide units linked by glycosidic bonds with chitosan 
(CS), cellulose (CL), starch, hyaluronic acid (HA), and dextran 
(DEX) being typical examples.25, 32 Similar to proteins and 
glycosaminoglycans, which are also common natural polymers, 
polysaccharides can be extracted from various sources, for 
instance, from plant origin, microbial origin and animal origin.25, 
33 The biological properties and activities of different 
polysaccharides are diverse due to their different chemical 
structures (Fig. 1) and ionic nature. Thus, their functions and 
applications are directly related to their chemical and 
biochemical specifications.25, 28 The properties of common 
polysaccharides which are widely used in nanomedicine, 
cosmetics, food, and other areas are summarised in Table 1, and 
more information is detailed in the following sections. 
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2.1 Chitin and Chitosan 
Chitin (CH) is the primary component of the crustaceans’ 
exoskeleton, and it is also the second most abundant natural 
polysaccharide.25, 45 A commonly employed derivative of CH is 
chitosan (CS), which is a linear polysaccharide obtained from 
the partial N-deacetylation of CH with a deacetylation degree of 
over 40% under alkaline conditions and elevated temperature 
(Fig. 1a).46 CH has a hydrophobic linear structure composed of 
β-(1,4)-linked N-acetyl-D-glucosamine units, while the structure 
of CS is mainly based on β-(1,4)-linked glucosamine and N-acetyl 
glucosamine units.28, 47  
CH is insoluble in water or in other common solvents. However, 
CS produced from the N-deacetylation process of CH has 
increased aqueous solubility. Acidic conditions promote the 
water solubility of CS due to protonation of the basic amino 
groups.28 In addition, the conversion of CH to CS decreases the 
molecular weight (MW) from an average range of 1000-2500 
kDa to 100-500 kDa. The lower MW of CS resulting from the 
deacetylation process can also facilitate the water solubility of 
CS.25, 28 The more frequent use of CS in NPs compared to CH can 
be deduced to the  improved water solubility. Furthermore, the 
amine functions of CS can be employed for chemical reactions, 
e.g. functionalisation, and CS can be produced in many kinds of 
forms, such as powder, paste, and film. Frequently, CS is utilised 
for the synthesis of widely used CS-based nanoparticles 
(CSNPs).28, 33 
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Fig. 1 Chemical structures of polysaccharides: a) Chitin (CH) and its derivative from N-deacetylation chitosan (CS), b) cellulose (CL), c) and d) structures of two different polymers 
coexisting in starch, amylose and amylopectin (dashed lines indicate branches), e) hyaluronic acid (HA), f) dextran (DEX) (dashed lines indicate branches), g) pullulan (PL), h) sodium 
alginate (α-L-guluronic acid - α-L-guluronic acid - β-D-mannuronic acid - β-D-mannuronic acid sequence shown), and i) -carrageenan (-CRG).  
As the nature of CS favours chemical modifications compared to 
less reactive CH, the preparation of CS-based nanoparticles 
(CSNPs) can be conducted by various avenues. Effective 
chemical modifications enable further options to use the 
material compared to the natural compound. The chemical 
modifications are usually carried out at the sites of reactive 
amino groups of CS, and there is a wide range of examples of 
commonly used CS derivatives such as thiolated CS, sugar-
bearing CS, and carboxyalkyl CS.25, 48 These CS derivatives are 
designed to enhance specific properties of CS. For instance, CS 
modified by thiol groups can obtain improved mucoadhesive 
properties, while conjugating hydrophobic moieties (e.g. 
deoxycholic acid and cholesterol) to CS introduces an avenue to 
form CSNPs by self-assembly.45, 48  
CS is widely investigated in many areas of applications, for 
example, drug delivery, tissue engineering, and stabilising 
cosmetic ingredients.45, 49, 50 The positive charge density on CS 
is thought as significant in improving the cell uptake, but it is 
accompanied with higher toxicity.25, 51 To solve this problem, 
the selection of suitable CS derivatives have attracted growing 
attention, in order to improve health benefits of CS.51  
2.2 Cellulose 
Cellulose (CL) is the primary constituent of plant cell walls, and 
it is the most abundant natural polysaccharide.28 As the base 
fundamental unit of plants, CL is considered as 
human/animal/environmental-friendly, biocompatible, and 
biodegradable.33, 52 CL is mainly extracted from plant origin, and 
its linear polysaccharide structure is formed by β-(1,4)-linked D-
glucose units, giving a flat ribbon-like conformation (Fig. 1b).52  
The CL polymer and polymer fibrils are relatively stable due to 
their inter- and intra-chain hydrogen bonding network. Thus, 
the linkage of individual CL chains is stabilised by 
supramolecular interactions, giving the linear configuration and 
an axial stiffness in CL fibrils. On the basis of CL biosynthesis and 
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extraction processes, various types of CL-based nanoparticles 
(CLNPs) and CL nanocomposite materials can be obtained. The 
main factors which cause the differentiation are the source 
materials of CL (e.g. wood, plant, and bacteria) and the 
deconstruction processes during extraction.52, 53  
For the utilisation of CL, many applications in diverse research 
areas are described, such as food packaging, drug delivery, 
films, and reinforcing materials for polymer matrices.33, 52 After 
appropriate surface functionalisation, the surface chemistry of 
CLNPs enables self-assembly, making CLNPs versatile materials 
with considerable mechanical properties.52  
2.3 Starch 
In plant tubers and seed endosperm, starch is the primary 
storage carbohydrate which can be extracted from many 
resources such as corn and potato.54 Chemically, two different 
polysaccharide structures are present in starch, which are 
amylose (Fig. 1c) and amylopectin (Fig. 1d). Amylose is a linear 
polymer formed by α-(1,4)-linked D-glucose units while 
amylopectin is a highly branched polymer composed of short 
chains of α-(1,4)-linked D-glucose units with branches formed by 
α-(1,6) linkages at the branch positions.54, 55  
The average MW of amylose is in the range of 105 Da while that 
of amylopectin is distributed from 106 to 107 Da. For example, 
rice starch has higher MW compared with those from corn, 
wheat, and potato, because rice starch has the lowest amylose 
content amongst them.51 Similar to CL, starch is insoluble in cold 
water due to the hydrogen bonding effect. Moreover, the high 
MW of starch decreases the solubility. In relation, amylopectin 
has higher solubility compared to amylose because of its highly 
branched structure, which is useful in separating amylose and 
amylopectin from starch granules.27, 51  
Starch-based NPs (SNPs) can be prepared by various strategies 
such as precipitation, solvent evaporation, and emulsion 
crosslinking. Moreover, different preparation methods will 
result in variation of SNPs properties (e.g. shape and 
crystallinity).33, 56 Compared with other polysaccharides, starch 
is unique because it has the property to convert to 
thermoplastic material in the presence of plasticisers. Also, 
starch has the advantages of stability, biocompatibility, and 
biodegradability, making it useful in drug delivery, tissue 
engineering, and food packaging applications. 33, 47  
2.4 Hyaluronic Acid 
As a typical extracellular matrix polymer, hyaluronic acid (HA) 
has broad applications in biomedical and nanotechnological 
areas. Regarding the structure of HA, it is a hydrophilic linear 
polysaccharide composed of alternately linked D-glucuronic and 
N-acetyl-D-glucosamine units via β-1,3 and β-1,4 glycosidic 
bonds (Fig. 1e).33, 43 As HA is a negatively charged 
polysaccharide, hyaluronic acid-based NPs (HANPs) can be 
formed by using cationic molecules (e.g. CS) as ionic 
crosslinkers. Moreover, approaches such as making HA-cargo 
(e.g. drug) conjugates have also been developed to form HA-
based nanocarriers.57, 58 HA is mostly extracted from living 
tissues, and it is significant in the areas of tissue repair, wound 
healing, food industry, and cosmetics. Moreover, HA is not only 
a good wound healing factor but also an adequate carrier for 
the delivery of antibiotics that aid in wound healing 
properties.28,15  
2.5 Dextran 
Dextran (DEX) belongs to the first commercial 
exopolysaccharide produced by bacterial enzymes and is mostly 
obtained from Leuconostoc mesenteroide. It is branched, and 
the basic structure of the various types of dextran consists of 
main chains formed by (1,6)-α-D-glucose with various ratios of 
linkages and branches (Fig. 1f).59 The ratios of α-(1,6) linkages 
can vary from 97% to 50%, and the branching can take place 
mainly in position α-(1,3), and occasionally in position α-(1,2) or 
α-(1,4).28, 59 Because of the reactive hydroxyl chemistries of DEX, 
it is easy to be functionalised.28 Furthermore, DEX is highly 
water-soluble and frequently used in ATPS.60, 61 Depending on 
the strain of bacteria and conditions used, properties of DEX 
such as branching and molecular weight vary considerably. The 
MW of DEX ranges from 3000 Da to 2,000,000 Da, and the larger 
DEX (>60,000) are excreted poorly from the kidney and remain 
in the blood before being completely metabolised.39, 62  
Non-ionic DEX-based NPs can be obtained by self-assembly, and 
due to the biocompatibility and biodegradability of DEX, NPs 
from DEX are discussed as suitable drug/gene nano-vehicles. In 
addition, the superior water solubility of Dextran-based NPs 
(DEXNPs) prevents cellular toxicity after completing the drug 
delivery process.63 Similar to CS and HA, the advantages of 
DEXNPs can be promoted after suitable chemical modifications 
or forming DEX-drug conjugates. Typical DEX derivatives such as 
thiolated DEX, phosphorylated DEX, and dextran sulfate (DS) are 
all very useful in enhancing the targeting ability of DEXNPs.26, 59, 
63 For example, the chemical modification of DEX to obtain DS 
enables interactions with lipoproteins and complexation with 
fibrinogen or DNA. Furthermore, modification with 
hydrophobic moieties introduces amphiphilicity, which is very 
important to form self-assembled and water dispersible DEXNPs 
in the field of drug delivery.26  
2.6 Pullulan 
Pullulan (PL) is a non-ionic exopolysaccharide which is mainly 
obtained from the fermentation medium of the fungus-like 
yeast Aureobasidium pullulans under limiting conditions. PL has 
been widely used in various areas because it is non-toxic, non-
mutagenic, non-carcinogenic, biocompatible, and bio-
degradable.64 The structure of PL is based on -(1,6) linked 
maltotriose units (Fig. 1g), and the linkage between maltotriose 
units significantly gives structural flexibility of PL.65, 66 PL is easily 
soluble in water and insoluble in most organic solvents. 
Compared with other polysaccharides, the PL aqueous solution 
is stable and has a relatively low viscosity. The MW of PL ranges 
from 100 kDa to 250 kDa, and its appearance is white or 
yellowish-white powder.44 PL hydrogel NPs have been 
employed for gene delivery67 or as composite with CS for 
vaccine delivery.68, 69 Recently, PL was utilised as block in double 
hydrophilic block copolymers, which were utilised in turn for 
self-assembly, for example in the formation of completely 
hydrophilic capsules,70 droplets71, 72 or particles.73 
Similar to DEX-based NPs, the PL-based NPs (PLNPs) can be 
prepared by self-assembly after the hydrophobic modification 
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of PL. In the fields of drug and gene delivery, hydrophobically 
modified PL has been widely investigated to be a good 
nanocarrier. Moreover, by mixing hydrophobically modified PL 
with quantum dots, the formed PLNPs can also play a significant 
role in medical tracing areas such as tumour imaging.32, 66 PL is 
also being used in the areas of food and cosmetics, for example 
to extend food shelf life and simplify food processing. For 
cosmetics, PL can be utilised in lotions, shampoos, and face 
masks.74  
2.7 Alginate 
Alginate is a well-known polysaccharide produced by brown 
algae and bacteria consisting of α-L-guluronic acid and β-D-
mannuronic acid building blocks that are linearly linked by 1,4-
glycosidic linkages (Fig. 1h).75 Alginate chains consist of blocks 
of either all α-L-guluronic acid, all β-D-mannuronic acid, or 
alternating α-L-guluronic acid - β-D-mannuronic acid subunits.76 
It is known to be biodegradable, non-toxic and abundant with 
molar masses between 32 and 400 kDa.34 The polymer is anionic 
due to the acid functions and frequently used in the form of 
sodium or potassium salts. A remarkable feature of alginate is 
its interaction of α-L-guluronic acid - α-L-guluronic acid subunits 
with divalent cations like calcium ions leading to hydrogel 
formation.76 These hydrogels are utilised in various medical 
applications,77 e.g. encapsulation of drugs and release78 or as 
cell growth environment.79 The complexation with Ca2+ can also 
be employed to form NPs for example via emulsion methods80 
or precipitation.81 Also, a combination with cationic CS enables 
NP formation via coacervation.82 
2.8 Carrageenan 
Carrageenans (CRG) are linear sulphated PS and originate from 
seaweed.35 The polymer structure consists mainly of 3-linked -
D-galactopyranose and 4-linked -D-galactopyranose or 4-
linked 3,6-anhydro--D-galactopyranose units (Fig. 1i with an 
example structure). CRGs are classified into six types based on 
the chemical structure (kappa ()-, iota ()-, lambda ()-, mu ()-
, nu ()- and theta ()-CRG), i.e. the position of sulfate esters and 
the presence of anhydro units. Overall, the MW of commercial 
CRG ranges from 100 to 1000 kDa with solubility in hot water 
and partially cold water depending on substitution. CRGs form 
helices in aqueous environment leading to gelation that is 
exploited in food industry for thickening.83 Due to its 
polyanionic character, CRG can be used in conjunction with CS 
to form NPs.84, 85 Nevertheless, the biocompatibility and toxicity 
of CRG is currently under discussion and has to be followed 
closely for food and biomedical applications in particular.86  
3. Synthesis of Polysaccharide Nanoparticles 
A variety of methods has been proposed to prepare NPs based 
on natural polysaccharides. The selection of a proper synthesis 
method depends on the targeted application and its 
requirements. For example, many factors such as thermal and 
chemical stability of the active agent, reproducibility of the 
release kinetic profiles, particle size, and stability of the final 
product and residual toxicity associated with the final product 
have to be taken into account before preparing drug delivery 
nanocarriers87 and NPs for other applications. The avenue for 
the preparation of NPs is crucial for stability under the intended 
conditions and in particular the crosslinking chemistry has to be 
considered. For example, the native charges of polysaccharide 
can be exploited for the synthesis of polysaccharide NPs88-90 or 
covalent crosslinking can be implemented.91-93 Mizrahy and 
Peer discussed the main mechanisms during the synthesis of 
polysaccharide NPs in their review in detail, which are 
categorised as chemical (covalent) crosslinking, physical (ionic) 
crosslinking, polyelectrolyte-complexation and self-assembly 
(Scheme 2).25 Due to the repeated number of monomer units 
on the polysaccharide a full network can be achieved. Hence, a 
complete gelation of the reaction medium has to be supressed 
via the preparation conditions, e.g. in disperse systems. 
In addition to the crosslinking process itself, the formation of 
NPs relies on the formation of materials on the nano scale via 
various preparative techniques. In this section, important and 
widely used methods (Scheme 3-5) such as nanoprecipitation, 
complex coacervation, and emulsification will be discussed. 
Also, the microfluidic technique has proven to be a useful 
direction for the preparation of polysaccharide NPs, both in 
emulsion and nanoprecipitation approaches.94 Other related 
methods developed by researchers will be reviewed as well. The 
relationship between the properties (e.g. diameter) of the 
polysaccharide NPs synthesised and the methods utilised will be 
discussed to showcase how the methods affect the final 
properties. 
3.1 Crosslinking and aggregation strategies 
As for common polymer NPs, one of the main concerns in the 
fabrication of polysaccharide NPs is the crosslinking of the 
polysaccharide to form stable particles. Crosslinking has a 
considerable influence on the polysaccharide NP properties and 
hence applications, e.g. mechanical properties, swellability or 
drug-encapsulation/release. 
Covalent crosslinking introduces irreversible crosslinking points 
leading to highly stable structures (Scheme 2a) that can 
withstand chemical stress, e.g. solvent changes or a broad pH 
range.25 The crosslinker molecules have to be multifunctional in 
order to react twice with a polysaccharide molecule or with 
other crosslinkers to form a connection between 
polysaccharide molecules. Common crosslinkers for 
polysaccharides are dialdehydes that link via acetal formation. 
Other options include multifunctional carboxylic acids forming 
ester or amide bonds. An avenue to introduce degradability or 
even stimulus response is the utilisation of cleavable 
crosslinkers.95 One of the issues with covalent crosslinking is the 
potential toxicity of remaining non-linked small molecules 
crosslinkers that might hinder biomedical applications. 
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Scheme 2. Avenues for the preparation of polysaccharide NPs: a) covalent crosslinking, 
b) ionic crosslinking, c) complexation of oppositely charged polysaccharides, d) self-
assembly of hydrophobically (blue sphere) modified polysaccharides and e) 
polysaccharide–drug (green sphere) conjugate.25 
Another way to introduce crosslinks is via a supramolecular 
pathway for charged polysaccharides, e.g. in ionic crosslinking 
(Scheme 2b). For that oppositely charged small ionic molecules 
with multiple functionalities are added, e.g. tripolyphosphate 
(TPP), or ions with multiple vacancies for interaction, for 
example Ca2+.96 The crosslinking proceeds via electrostatic 
interactions that connect the crosslinker with the 
polysaccharide. In contrast to covalent crosslinking, ionic 
crosslinking features a lower chemical stability, e.g. against 
changes in pH or ionic strength, and also physical stability, e.g. 
against temperature changes. However, this defined instability 
can be exploited to enable degradation on purpose, for example 
in drug-delivery applications.95 
A crosslinking method of high relevance is coacervation or 
polyelectrolyte complexation of charged polysaccharides. In 
order to form coacervate structures, oppositely charged 
polysaccharides and/or polyelectrolytes are employed. In a 
similar way to ionic crosslinking, electrostatic interactions lead 
to crosslinking (Scheme 2c). As no toxic small molecule 
crosslinkers are used, the coacervate approach is considered 
highly biocompatible at least if the employed 
polyelectrolytes/polysaccharides are biocompatible. The 
obtained stability of the NPs relies on charge density and 
distribution of charges along the chain, as the interaction 
between both polyelectrolytes/polysaccharides is the main 
factor for stability.97 Similar to ionic crosslinking, pH, ionic 
strength and temperature play a crucial role for the stability and 
preparation of coacervate particles. Polysaccharides like HA, CS 
and alginate are utilised frequently for coacervate formation. 
Coacervation/polyelectrolyte complexation can be also utilised 
in the formation of layer-by-layer assemblies.98, 99 
Self-assembly of polysaccharide chains can be employed for NPs 
formation as well, which is another supramolecular avenue.100 
Commonly, hydrophilic polysaccharides are functionalised with 
hydrophobic moieties (bile acids, fatty acids or cholesterol) that 
will aggregate in aqueous environment leading to micellar 
structures (Scheme 2d).101, 102 As such, NPs with hydrophobic 
core and hydrophilic polysaccharide shell are obtained. The 
core can perform as a reservoir for hydrophobic drugs or other 
molecules. The properties of the micellar NPs can be tailored via 
the utilised polysaccharide conjugate, e.g. MW or hydrophobic 
to hydrophilic ratio, but also via the preparation process, e.g. 
the kinetics of micelle formation or the utilised solvent system. 
The approach was brought to the next level by Wich and 
coworkers,103 who synthesised an amphiphilic block copolymer 
of DEX and hydrophobic acetalated DEX and formed micellar 
NPs that way. As such, a completely polysaccharide-based 
amphiphilic block copolymer was presented.  
At last, a related structure to micelles should be discussed, 
namely polysaccharide-drug conjugates (Scheme 2e).48 Instead 
of adding non-functional hydrophobic molecules to drive 
supramolecular aggregation, hydrophobic drugs can be 
conjugated as well to the polysaccharide. As such, 
polysaccharide NPs can be obtained that serve as drug-delivery 
vehicles directly. An important characteristic is the connection 
of drug and polysaccharide that should be cleavable in the body 
at best at the right point of action.104 In principle, also other 
methods of aggregation or crosslinking can be combined with 
polysaccharide-drug conjugates. 
3.2 Nanoprecipitation 
Nanoprecipitation is one of the first developed techniques for 
encapsulating drug molecules, and it is also known as solvent 
displacement or interfacial deposition. Nanoprecipitation has 
been widely used in the formation of many kinds of NPs such as 
polymeric NPs, drug NPs, drug-loaded protein NPs and inorganic 
NPs.105 Though nanoprecipitation has advantages of being 
simple, reproducible, fast, and economic, it is still challenging to 
encapsulate water soluble compounds with this method.106  
In the nanoprecipitation process, two miscible phases are 
required, which are an aqueous phase and an organic/oil 
phase.107 A typical procedure (Scheme 3) of nanoprecipitation 
consists of dissolving hydrophobic solutes in a water-miscible 
solvent wherein they have high solubility at first. Subsequently, 
this solution is added to a significant excess amount of an anti-
solvent such as water or buffer solutions. Because the solubility 
of hydrophobic solutes decreases in the aqueous solution, 
particles of hydrophobic compounds will precipitate. Finally, 
particles of hydrophobic molecules are obtained after removing 
the excess solvent by evaporation, dialysis, or lyophilisation.105 
The work of Barresi and coworkers showed that mixing of 
phases has a significant effect on controlling the particle size.108 
Briefly, a larger population of smaller NPs can be obtained from 
good mixing conditions, while poor mixing produced larger NPs. 
The NP formation also relies considerably on the surface tension 
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difference between aqueous phase (with high surface tension) 
and organic phase (with low surface tension). The difference in 
surface tension leads to continuous solvent vortices formation 
at the interface of both liquids, and the organic solvent diffuses 
from low surface tension, causing gradual precipitation of the 
polymer (e.g. polysaccharides) on the organic surface and 
formation of nanocapsules.109  
 
Scheme 3. Schematic representation of the nanoprecipitation method.  
Zhao and coworkers discussed three widely used 
nanoprecipitation methods in their work, which are traditional 
nanoprecipitation, flash nanoprecipitation, and micro-fluidic 
nanoprecipitation.105 To control the size and morphological 
structure of the NPs prepared, key parameters such as mixing 
temperature, solvent/antisolvent ratios, and properties of the 
chosen polymers are very important. Operation of traditional 
nanoprecipitation is easy, quick, and affordable. However, it has 
a lack of control over mixing and has wider size distributions of 
large particle sizes.105 Flash nanoprecipitation is a simple, rapid 
and scalable method. Turbulence-based intensive mixing can be 
achieved within few milliseconds by using flash 
nanoprecipitation mixers. Therefore, flash nanoprecipitation 
produces better NP quality with smaller NP size and narrow size 
distribution.105, 110 The limitation of flash nanoprecipitation is 
that the particles produced do not have adequate stability for 
some applications.105 Micro-fluidic nanoprecipitation is usually 
laminar flow-based and operated in continuous flow, its high-
speed diffusion-based mixing (at milliseconds or even 
microseconds) results from a reduced mixing path (down to 
several tens of nanometres). By changing the configuration of 
the micromixer or controlling the ratio of flow rates, 
physicochemical properties of NPs (e.g. size, charge, 
morphology) can be controlled. However, an issue is system 
blocking caused by solid particle accumulation. Moreover, small 
volume and low flow rates in microfluidics result in relatively 
low productivity.105, 111  
 
Fig. 2 Examples of polysaccharide NPs obtained by the nanoprecipitation method 
observed via Scanning Electron Microscopy (SEM) (scale bar 1 µm): a) Micrograph of 
precipitated SNPs prepared by addition of 1 mL of 1% starch into 20 mL of ethanol,  b) 
micrographs of precipitated SNPs prepared by addition of 1 mL of 1% starch into 20 mL 
of ethanol with 4% of cetrimonium bromide surfactant and c) micrographs of 
precipitated SNPs prepared by addition of 1 mL of 1% starch into 20 mL of ethanol with 
4% of Tween 80 surfactant. (Reproduced with permission from 112. Copyright Elsevier, 
2011.) 
As a simple and rapid method, nanoprecipitation has been used 
to prepare various types of polysaccharide NPs. Tay and 
coworkers synthesised SNPs with sizes in the range between 
300 nm and 400 nm by adding dissolved starch solution into 
excess ethanol under controlled conditions (Fig. 2a).112 The 
presence of appropriate surfactant was also an important 
parameter in modulating the shape and size of the produced 
SNPs (Fig. 2b/2c). NPs of hydrophobically modified CL were also 
synthesised by using nanoprecipitation method. Kulterer et al. 
prepared cellulose acetate (CA) NPs by developing an efficient 
nanoprecipitation technique based on using good CA solvents 
as a modifier for the nonsolvent.113 The size of NPs was reduced 
by sonication, efficient agitation, and optimisation of process 
parameters such as tetrahydrofuran (THF) content, 
temperature and pH value. Spherical NPs of 60 nm with high 
yield were obtained by adding good polymer solvents (THF) to 
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an anti-solvent (water). A nanoprecipitation process for the 
formation of DEX NPs was described by Weiss and coworkers.114 
Initially, DEX, PL and starch were methacrylated via methacrylic 
anhydride to enable crosslinking and the hydrophile-lipophile 
balance (HLB) value measured. In the next step, the modified 
polysaccharides were dissolved in acetone or THF, precipitated 
in water and crosslinked under UV light. The obtained particles 
were subjected to atomic force microscopy (AFM) 
measurements in order to obtain mechanical properties. 
Interestingly, the Young’s moduli of particles correlated with 
the HLB value of the utilised polysaccharide, which might be due 
to the difference in water swelling for particles with different 
HLB value. Nicolas and coworkers utilised nanoprecipitation in 
the formation of polysaccharide capsules employing a 
template.115 Various polysaccharides were employed, e.g. DEX, 
PL, DS or HA, and crosslinked via isophorone isocyanate during 
the nanoprecipitation process. Mygliol as templating agent was 
dissolved together with the crosslinker in acetone and the 
polysaccharides added in aqueous solution at once. In addition 
to forming capsules from one polysaccharide component, 
blends were introduced as well as multilayers.  
Overall, nanoprecipitation is easy to conduct with fast operation 
processing and simple equipment requirement. However, 
issues such as low productivity and system blocking during the 
NPs formation need more attention in future development.105 
Thus, improved control for fast processing is required and more 
complex structures have to be investigated in the future. 
3.3 Complex Coacervation 
The complex coacervation method is carried out by mixing 
aqueous solutions of two polymers with opposite charges. It is 
a suitable method for the preparation of NPs due to its 
simplicity and mild preparation conditions without the need of 
organic solvents.19 To synthesise and enhance natural 
polysaccharide NPs, complex coacervation with oppositely 
charged polyelectrolytes has been widely used.116  
The mixing of solutions containing oppositely charged 
polyelectrolytes (polycation and polyanion) (Scheme 4) 
establishes an equilibrium between the dense liquid phase and 
the dilute solution phase. The dense liquid phase is also called 
the coacervate, which is polyelectrolyte-rich and frequently 
produced from proteins and polysaccharides.117, 118 According 
to the theoretical model of Voorn and Overbeek, the 
association of polyelectrolytes is significantly determined by the 
electrostatic interaction and the entropy gain during the 
complex coacervation process.118, 119 Related to this, many 
important modes of polymer complex coacervation including 
the Voorn-Overbeek theory were reviewed by Sing.120  
An interesting feature of the complex coacervation process of 
polyelectrolytes, is that the net charge of the NPs formed can 
be modulated by adding one polyelectrolyte in excess to the 
other, giving a core-shell structure with the excess component 
segregated at the outer shell. The physical properties of the 
polyelectrolyte-complex formed by coacervation can be 
affected by many factors such as pH of the solution, 
temperature, ionic strength, charge density, and the molar 
mass of polyelectrolytes.32, 106 For instance, Delair and 
coworkers found improved stability of the polyelectrolyte-
complex formed by DS (polyanion) and CS (polycation) by 
remaining the charge ratio R (n+/n-) under 0.6.121  
 
Scheme 4. The typical processes of forming polysaccharide NPs such as CS/HA NPs by 
complex coacervation process.  
For polyelectrolyte-complex formation, CS is the most 
commonly used cationic polysaccharide. Besides, various 
negatively charged polysaccharides such as HA, DS, and 
carboxymethyl cellulose can be combined with CS.32 Chen and 
coworkers prepared NPs made of oleoyl-carboxymethyl-
chitosan (OCMCS) and HA for gene delivery using the 
coacervation process.122 The results obtained from their work 
showed that a charge ratio of 5 (n-/n+) and a weight ratio of 4 
(OCMCS/HA) were the optimal conditions giving the smallest 
(165 nm), positively charged (+14.2 mv) and monodisperse NPs 
(Fig. 3a). Ferreira and coworkers developed a pH sensitive CS/DS 
NP system for the delivery of insulin using complex 
coacervation.123 The optimum synthesis conditions had a DS:CS 
mass ratio of 1.5:1 at pH 4.8, and the stable spherical NPs 
produced had a mean diameter of 500 nm. It was also found 
that the insulin released by CS/DS NP system maintained its 
immunogenic bioactivity, indicating a bright future for the 
CS/DS NPs as a potential oral delivery system for insulin. Dou 
and coworkers124 described the formation of complex 
coacervates as well. At first, CS/DEX nanoparticles were formed 
via in situ crosslinking and self-assembly. CS and DEX were 
dissolved in water and radicals formed on polysaccharide 
backbones via addition of cerium (IV) ions that initiated the 
formation of poly(methyl acrylate) (PMA) and crosslinking via 
diallyldisulfide. Due to the formation of hydrophobic grafts an 
amphiphilic structure was generated that assembled into NPs. 
In a subsequent step, these particles were combined with HA to 
obtain a larger super structure via coacervation (Fig. 3b). The 
formation of multi-particle aggregates or HA-surface modified 
particles could be tailored via the ratio of HA and particle 
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precursors. Finally, the particles were employed to target 
cancer cells via the lipid raft-dependent endocytosis pathway. 
 
Fig. 3 Examples of polysaccharide NPs obtained by using the complex coacervation 
method: a) oleoyl-carboxymethyl-chitosan (OCMCS)- hyaluronic acid (HA)/DNA NPs with 
a charge ratio of 5 (n-/n+) and a weight ratio of 4 (OCMCS/HA) (scale bar 500 nm) and 
(Reproduced with permission from 122. Copyright Elsevier, 2013.). b) TEM image of 
HA/CS/DEX NPs formed via coacervation of CS/DEX NPs with HA. (Reproduced with 
permission from 124. Copyright American Chemical Society, 2020.)  
The influence of CS acetylation degree on the synthesis, 
stability, and performance of CS/HA NPs prepared by 
electrostatic complex coacervation was studied by Furlani et 
al.125 A crosslinking mechanism mediated by TPP was involved 
because the inter-polyelectrolyte interaction between CS and 
HA alone was not sufficient to form spherical particles. The 
synthesis of NPs was carried out as follows. First, CS, sodium 
hyaluronate, and TPP were dissolved individually in deionised 
water. After solubilisation, HA/TPP solution was prepared by 
adding TPP solution dropwise to the hyaluronate solution. Then, 
the formation of NPs was conducted by adding the HA/TPP 
solution dropwise to CS solution under stirring. The results of 
their work proved that CS acetylation degree determines the 
NPs stability, and CS with specific fractions of acetylated units 
such as 0.16 and 0.63 were found to promote the formation of 
homogenous NPs. Recently, Tirelli and coworkers studied the 
formation of CS/HA-based nano particles with respect to the 
effects of template addition.126 A two-step templating process 
was compared with a direct polyelectrolyte complexation 
approach. The two-step templating was performed via 
ionotropic gelation of CS with TPP and subsequent incubation 
with HA. It could be shown that HA can quantitatively exchange 
with TPP in the second step, which was accompanied with 
aggregation of particles. In contrast to the direct process of 
CS/HA complexation, larger particles were generated. 
Furthermore, the utilisation of low MW CS induced the 
formation of a HA corona.  
Another key feature of complex coacervation is the 
preservation of the structure and property of biochemical drugs 
including genes and proteins, which is due to the mild 
conditions required for coacervate formation and their native 
environment.127 In addition, the complex coacervation process 
enables the formation of polysaccharide NPs with high loading 
of biomolecular cargo.128 Although there has been considerable 
progress in the theory of coacervation,120, 129 the prediction of 
outcomes from the preparation procedure is challenging,130 e.g. 
the control over NPs size and shape. This is mainly due to the 
various parameters in coacervate preparation like pH, ionic 
strength, polymer concentration, temperature and polymer 
type/MW. To improve the performance of NPs in the drug 
delivery system, the mixing of polysaccharide with other 
polymers can also be achieved using complex coacervation 
method.19 As such, access to additional features is possible, e.g. 
structures with poly(ethyleneglycol) (PEG) corona.131 
3.4 Emulsion-based Methods 
As a regular method for preparing polymer NPs,132, 133 emulsion-
based procedures are also a versatile method used for the 
synthesis of polysaccharide NPs.19 The term emulsification is 
defined as a process of forming a metastable dispersion (e.g. oil 
and water) also called emulsion that would separate into two 
phases in equilibrium. In biological systems different uses of 
emulsions are found, for example, lipoprotein forms an 
emulsion for the delivery and metabolism of fat in the body.30, 
134  
 
Scheme 5. Schematic overview over the emulsion process for polysaccharide NP formation: a) formation of polysaccharide NPs via water-in-oil emulsion and crosslinking (external 
gelation) and b) types of emulsions used to prepare polysaccharide NPs (green: organic solvent; blue: water). 
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Generally, depending on the type of dispersed phase and 
dispersion medium, emulsions are categorised as O/W direct 
emulsion and water-in-oil (W/O) inverse emulsion, in which 
water or oil is the continuous phase, respectively. Besides, more 
complex multiple emulsions such as oil-in-water-in-oil emulsion 
and water-in-oil-in-water emulsion can also be obtained by 
dispersing the O/W or W/O emulsions in oil or water using 
specific techniques (Scheme 5).134 In addition, W/W emulsions 
can be formed as well (refer to Section 4.3).135, 136 Considering 
the size of droplets, emulsions formed can be classified as 
microemulsion, miniemulsion and macroemulsion. 
Microemulsions are thermodynamically stable with droplet 
sizes ranging from 10 to 100 nm. Miniemulsions and 
macroemulsions are both thermodynamically unstable with 
droplet sizes between 100 nm and 1 µm and larger than 1 µm, 
respectively.30  
Different from the nanoprecipitation method mentioned 
above, which is a simple one-step method, preparation of 
organic NPs such as polysaccharide NPs using emulsification 
method is based on a two-step procedure. At first the emulsion 
is prepared as mentioned above and subsequently, NPs can be 
generated from the emulsion via various methods, such as 
solvent evaporation, solvent diffusion, and reverse salting-
out.137 In particular, the formation of polysaccharide NPs by 
emulsification method is conducted as follows: A solution of 
polysaccharide is firstly formed by dissolving polysaccharides in 
deionised water or other solvents. Secondly, the solution is 
dispersed in an oil phase to fabricate O/W or W/O emulsions by 
stirring or employing ultrasound. Polysaccharide NPs can finally 
be prepared by internal or external gelation.19 In external 
gelation, the crosslinkers diffuse from an external source into 
the polysaccharide emulsion, i.e. from the continuous phase. 
While for internal gelation, the crosslinkers are already present 
inside the droplets before gelation occurs.138  
To obtain the emulsification system, low-energy emulsification 
techniques and high-energy emulsification techniques are 
commonly used. The former one is based on the expansion of 
low-energy stirring routes in constant progress. It can be 
classified as spontaneous emulsification, emulsion inversion 
point method, and phase inversion temperature method. For 
high-energy emulsification, high-energy mechanical stirring 
processes such as sonication and microfluidic methods are 
employed, the applied stress predominately determines the 
size of the nanodroplets produced.30 Ravi et al. successfully 
prepared Lopinavir loaded pullulan acetate NPs (PANPs) for oral 
delivery using O/W emulsion-solvent-evaporation method in 
their study.139 Firstly, Lopinavir and pullulan acetate were 
dissolved in methylene chloride giving the organic phase. 
Subsequently, to form the emulsification system, the organic 
phase was added dropwise to an aqueous poly(vinyl alcohol) 
(PVA) solution under gentle magnetic stirring, where PVA acts 
as steric stabiliser for the PANPs. After a 15 min high-speed 
homogenisation, the primary emulsion was centrifuged to 
obtain the PANPs. Further purification was finally conducted to 
remove the excess free drug and PVA before storage. According 
to the results of their work, the size of PANPs prepared was 
about 197 nm, high entrapment efficiency (∼75%) and 
monodisperse particles were also obtained. Moreover, a tissue 
distribution study proved that Lopinavir loaded PANPs could be 
a remarkable approach in treating HIV infection. 
 
Fig. 4 Polysaccharide NPs obtained by using the emulsification method: a) Schematic 
approach of HA-SS-DDT-DOX utilisation in cancer treatment and b) Fluorescence 
microscopic images of SCC7 cells treated with HA-TDA-DOX and HA-SS-DDT-DOX showing 
the release of DOX in cells in the case of HA-SS-DDT-DOX. (Reproduced with permission 
from 140. Copyright Elsevier, 2014.)  
In the study of Park’s group, Doxorubicin (DOX) loaded HA-
based nanocarriers for the intracellular DOX delivery were 
synthesised by using the O/W emulsion method (Fig. 4a).140 The 
HA-SS-DDT-DOX NPs formed were based on an amphiphilic HA 
derivative, the HA-SS-DDT, which was prepared by modifying 
HA with dodecanethiol (DDT) via disulfide linkage. The primary 
O/W emulsion was prepared by adding a solution of DOX HCl 
and triethylamine in chloroform, into the aqueous HA-SS-DDT 
solution. After evaporation of chloroform, the solution was 
filtered, dialysed, and lyophilised to obtain HA-SS-DDT-DOX NPs 
with a diameter around 334 nm. It was found that the 
synthesised NPs were stable under physiological conditions and 
DOX was effectively encapsulated with loading efficiency >70%. 
Moreover, the HA-SS-DDT NPs were effectively taken up by 
squamous cell carcinoma (SCC7) cells followed by fast release of 
DOX, indicating the promising future of HA-SS-DDT NPs as a 
potential DOX carrier (Fig. 4b). Sagis and coworkers utilised 
sodium alginate to form NPs via an emulsion process.141 
Alginate was dissolved in water and the aqueous solution 
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emulsified in an oil with polyglycerol polyricinoleate as 
surfactant. Then, CaCl2 nanoparticles were added to induce an 
external gelation process of the alginate via Ca2+/alginate 
complexation. 
Another kind of HA-based NPs were prepared by Min et al. with 
the O/W emulsion method.142 In aqueous conditions, HA-5β-
cholanic acid conjugates were firstly used to form HANPs by 
self-assembly. Subsequently, a bioinert and hydrophobic 
perfluoropentane (PFP) solution was added to the prepared 
HANPs and emulsified to fabricate PFP-loaded HANPs. The 
analysis results demonstrated that the PFP-loaded HANPs were 
stable and robust and had a homogeneous as well as narrow 
size distribution with an average diameter of 350 nm. 
Sriamornsak and coworkers described the formation of dextrin 
NPs via an inverse emulsion approach.143 Water-in-hexane 
emulsions were employed and dextrin crosslinked with glyoxal. 
Particle sizes were tailored via sonication time, surfactant type 
and concentration as well as HLB value. In a similar way, Gupta 
and coworkers formed nanoparticles from PL with sizes below 
50 nm.144 
Emulsification methods have a considerable advantage in 
controlling the size and loading of the synthesised 
polysaccharide NPs due to the convenient adjustment of 
emulsion droplet sizes and the option to include cargoes in 
specific phases of the emulsions. Nevertheless, emulsion 
methods are more complicated than nanoprecipitation and 
complex coacervation caused by the additional step of 
emulsification. Furthermore, the requirements of large 
amounts of organic solvents limit the utilisation of 
emulsification method.19  
3.5 Other Methods 
In addition to the three important methods introduced above, 
there have been other practical methods such as desolvation 
and dialysis, developed by researchers for preparing 
polysaccharide NPs, which are also appropriate in producing 
stable and monodisperse polysaccharide NPs with controllable 
size.19  
When using the desolvation method, a desolvation factor such 
as salts or alcohols is slowly added into the solution of 
macromolecules to induce polymer precipitation.30 For making 
drug nanocarriers, the selection of desolvating agents is based 
on the nature of the drug to be encapsulated inside the 
polysaccharide NPs.19 Amoabediny and coworkers synthesised 
curcumin loaded CSNPs and SNPs using the desolvation method 
in their work.145 The desolvating agent was composed of 
absolute ethanol and predetermined concentrations of 
curcumin. The CSNPs and SNPs were formed by ethanol 
precipitation of an aqueous CS/starch solution. Mean sizes of 
the synthesised curcumin loaded CSNPs and SNPs were 66 and 
61 nm with a maximum loading efficiency of 12% and 14%, 
respectively. The desolvation method can produce NPs directly 
in suspension in an aqueous medium, however, a further 
purification step is required because of the potential toxicity 
caused by desolvating agents.19  
Related to the nanoprecipitation method, a solvent 
displacement mechanism is used in the dialysis method. 
Additional tools such as dialysis tubes or semi-permeable 
membranes are utilised to provide a physical barrier with 
appropriate molar mass cut off for polymers/polysaccharides.30 
Zhang and coworkers synthesised paclitaxel (PTX) loaded HA 
NPs by using dialysis method.146 HA was modified first by 
coupling HA with aminated retinoid acid. Next, PTX solution in 
ethanol was added into the solution of retinoic acid modified 
HA (HRA). The obtained solution was then dialysed against 
distilled water, and the PTX-loaded HRA NPs were finally 
collected after filtration and lyophilisation. The particle size of 
the prepared PTX-loaded HRA NPs was around 149 nm, and the 
inhibition effect showed by PTX-loaded HRA NPs on tumour 
growth proved its future application in cancer chemotherapy. 
Compared to Nanoprecipitation, the dialysis method relies on a 
slow exchange of solvent and thus more likely generates 
thermodynamic products. 
Synthesis of NPs using ionic gelation is regularly performed with 
charged polysaccharides in aqueous medium in very dilute 
solution. For instance, CSNPs can be produced by ionic gelation 
because it is positively charged at neutral pH and can form NPs 
by crosslinking with small molecules (e.g. the monomers to 
form polymers) with opposite charge via electrostatic 
interaction.19, 30 Alonso and coworkers successfully entrapped 
DOX into CSNPs through the ionic gelation of CS with TPP.147 CS-
DOX complex was firstly prepared by adding DOX into the CS 
aqueous solution at pH 5.5. Subsequently, a suitable amount of 
TPP was mixed with the CS-DOX complex to form the DOX 
loaded CSNPs. According to the results obtained from their 
study, though the complexation efficiency was low, no complex 
dissociation was found after the formation of NPs. Moreover, 
the usefulness of CSNPs as the DOX carrier and to transport it 
into the cells in its active form was demonstrated. 
Spray-drying is a technique notably used in the production of 
powders, granules or agglomerates from the mixture of drug 
and excipient solutions as well as suspensions.19, 87 A typical 
spray-drying process is based on drying of aerosol droplets in 
contact with a hot drying gas to evaporate the moisture and to 
form the solid product.30 Li et al. described the preparation of 
NPs formed by modified starch in their study.148 The results 
showed that state-of-the-art spray drying equipment could 
lower the size of the produced dried particles by an order of 
magnitude attaining submicron sizes. Also, there are many 
factors possible to affect the size of the NPs produced. In the 
review of Agnihotri et al.,87 various parameters such as the size 
of the nozzle, spray flow rate, and atomisation pressure are 
discussed that can be controlled to obtain desired the particle 
size. 
Including what has been introduced above, there are many 
other practical techniques for polysaccharide NP synthesis that 
complement the most common methods and cannot be 
covered in the present review. Overall, further studies are still 
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4. Polysaccharide Nanoparticles and Polymers 
Developing NP systems formed by polysaccharides and 
polymers have potential applications in many areas such as drug 
delivery, Pickering emulsifiers, and improving the properties of 
polymer-based materials.70, 149-151 As such, 
polysaccharide/polymer NP systems combine the advantages of 
both polysaccharides and polymers, bringing benefits to 
overcome difficult challenges that belong to the individual 
materials (Scheme 6). For example, poly(ethyl acrylate) (PEA) or 
PMA polymers can introduce flexibility to rigid starch-based 
materials for further utilisation.152, 153  
 
Scheme 6. Schematic representation of the polysaccharide NP incorporation with 
polymer systems: a) polymer-grafted polysaccharide NP and b) polysaccharide NPs in a 
polymer matrix.  
This section will mainly focus on the methods of attaching 
polymers to polysaccharide NPs and inclusion of polysaccharide 
NPs into polymer structures. The system formed by the 
inclusion of polysaccharide NPs into the bulk of polymers is also 
known as a typical core-shell-structured hybrid or composite 
material. The core-shell structure is based on a sufficient 
modification of the surface of polysaccharide NPs by synthetic 
polymers, giving a polysaccharide NP core and a polymer 
shell.150 Moreover, in some cases, hydrophobic polymer NPs 
can also be used to form a core modified by outer hydrophilic 
polysaccharides. In the field of drug/gene delivery, the 
hydrophobic-hydrophilic core-shell structure plays a very 
significant role in enhancing the stability, water solubility and 
biocompatibility of NP structures.154-156 The polymer core – 
polysaccharide shell structure will not be discussed in detail in 
this section as it is not directly related to polysaccharide NPs, 
more related information of how the core-shell structure with a 
polysaccharide shell is utilised and can be found in the 
literature.157, 158 
4.1 Polymers Attached to Polysaccharide NPs 
Though polysaccharide NPs have been widely investigated in 
many research areas, for several applications, their 
hydrophilicity precludes further use of them. For example, to 
enhance the properties of hydrophobic polylactide (PLA), 
starch/PLA composites have been considered as an efficient 
choice. However, the hydrophobic PLA is immiscible with native 
hydrophilic starch, causing incompatibility and weak 
mechanical properties.153 Thus, improved compatibilisation via 
polymer attachment is a considerable direction.  
To effectively combine the advantages of polysaccharide NPs 
and polymers, graft modification/copolymerisation methods 
are necessary. Two types of grafting reactions can be conducted 
to form the polymer grafted polysaccharide system, i.e. the 
“grafting to” and “grafting from” reactions.159 In “grafting to” 
reactions (Scheme 7a), functionalised polymers are prepared in 
advance to be reacted with functional groups present on the 
polysaccharide interface/polysaccharide backbone. Moreover, 
the polymer chains to be grafted can be fully characterised 
before attachment. In “grafting from” reactions (Scheme 7b) 
the polymerisation of monomers takes place directly on the 
polysaccharide interface started from the polysaccharide 
backbone, which minimises the steric hindrance. In this case, 
the full characterisation of the grafted chain becomes 
challenging if not impossible.160  
 
Scheme 7. Schematic representation of the two grafting approaches. (a) The “grafting 
to” approach involving the coupling between the polysaccharide NPs and the pre-formed 
polymer chains (blue line). (b) The “grafting from” approach relying on polymerisation 
initiated at the NP surface (initiator/transfer agent: black sphere; monomer: blue 
sphere). 
According to Cunningham and coworkers, SNPs could be 
modified with synthetic polymers by using the two grafting 
reactions mentioned above via nitroxide-mediated 
polymerisation.31, 159 The “grafting from” approach was carried 
out in three main steps under inert conditions, which are SNP-
macroinitiator preparation, “grafting from” reaction, and acid 
hydrolysis (purification). Graft modified SNP with poly(methyl 
methacrylate-co-styrene) (P(MMA-co-S)), PMA, and poly(acrylic 
acid) were successfully obtained. In addition, the feasibility of 
varying the amount of grafted polymer on the SNP surface was 
demonstrated.31  
As well as SNPs, CSNPs were also studied for forming core-shell-
structured hybrids. In the work of Tang et al., two types of 
polymers were investigated to modify the surface of CS 
nanospheres (spherical CSNPs) via an ATRP “grafting from” 
process.161 The used polymers were the homopolymer 
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poly(methyl methacrylate) (PMMA) and amphiphilic block 
copolymer PMMA-b-poly(poly(ethylene glycol) methyl ether 
methacrylate) (PMMA-b-P(PEGMA)). The obtained structure 
had a CS nanosphere core and a densely grafted outer PMMA 
or PMMA-b-P(PEGMA) layer. The CSNP-g-(PMMA-b-P(PEGMA)) 
core-shell structure described the inclusion of a polysaccharide 
core in multipolymer layers. According to the results of the 
stability studies, the block copolymer grafted nanospheres 
CSNP-g-(PMMA-b-P(PEGMA)) were more stable in both THF and 
deionised water compared to the Br functionalised CSNP and 
CSNP-g-PMMA, indicating the potential use for the synthesis of 
CSNPs based core-shell structure for in vivo biomedical 
applications and industrial-scale polymerisation. 
Yuan et al. grafted poly(hydroxy ethyl methacrylate) (PHEMA) 
from crosslinked CS microspheres via an ATRP approach.162 
There, CS spheres were conjugated with an ATRP initiator and 
HEMA polymerised. In the following step, the hydroxyl groups 
from the HMA units were exploited to attach melamine in 
amide formation via a carbonyl diimidazole activation. As such, 
microspheres were obtained that featured considerable and 
rapid Cu(II) adsorption from aqueous solution. Moreover, the 
microspheres could be recycled via exchange with H+ ions. 
Another route for the formation of polymer decorated CS 
microspheres was presented by Peixão et al. Cerium(IV) 
initiation was employed to graft N-isopropylacrylamide) 
(NIPAM) directly from the crosslinked microspheres.163 
Additionally, the microspheres were embedded with magnetite 
nanoparticles to introduce magnetic features. The final 
microspheres featured thermosponsivity due to PNIPAM and 
could be easily separated from liquid media via magnetic field. 
In particular, the system was utilised to remove oil from water, 
i.e. the microsphere material was added to oily water to capture 
the oil and separate with a magnet. At ambient temperature a 
removal efficiency of 85% was observed, while an efficiency of 
97% was observed above 40 °C. This difference is due to the fact 
that the PNIPAM is more hydrophobic above its lower critical 
solution temperature and thus more susceptible to absorb oil.  
Similarly, “grafting to” approaches were also investigated to 
obtain grafted polysaccharide NPs, e.g. SNP under inert 
conditions.159 SNP was firstly functionalised with 4-vinylbenzyl 
chloride (VBC), and in a separate step, the N-tert-butyl-N-[1-
diethylphosphono-(2,2-dimethylpropyl) nitroxide] (SG1)-
capped P(MMA-co-S) was synthesised. Finally, the prepared 
SNP-VBC and SG1-capped P(MMA-co-S) were reacted to form 
graft modified SNP. The “grafting to” approach allows accurate 
and precise characterisation of the precursors and the grafted 
SNP. Wang and coworkers synthesised core-shell NPs based on 
an SNP-based core and a PNIPAM brush shell using surface-
initiated single-electron transfer living radical polymerisation 
(SI-SET-LRP) in their work.150 SNPs were firstly initiator-modified 
by Br groups using an esterification reaction (Fig. 5a). 
Subsequently, PNIPAM chains were grafted to initiator-
modified SNPs by using SI-SET-LRP. Compared with the initial 
SNPs, the SNP-g-PNIPAMs revealed an evolution in particle 
morphology (Fig. 5b-i), proving the successful synthesis.  
 
Fig. 5 a) Schematic overview of PNIPAM grafting from SNPs with the degree of 
substitution of the Br group around 1.1 per saccharide unit, b) and c) SNP-g-PNIPAM after 
15 min (SEM top :scale bar 1 µm, TEM bottom: scale bar 500 nm) , d) and e) SNP-g-
PNIPAM after 30 min (SEM top, TEM bottom), f) and g) SNP-g-PNIPAM after 60 min (SEM 
top, TEM bottom), h) and i) SNP-g-PNIPAM after 120 min (SEM top, TEM bottom). 
(Reproduced with permission from 150. Copyright American Chemical Society, 2019.) 
A “grafting-to” approach was employed by Lin and coworkers to 
form polysaccharide NPs with heparin core and PEG shell.164 The 
anionic polysaccharide heparin was combined with poly(lysine) 
to form NPs via coacervate formation under ultrasound 
treatment. To enable conjugation with PEG, the heparin chains 
were modified with tetrazine units. Finally, norbornene end 
functionalised PEG was added to the NPs to enable grafting. 
Subsequently, cell interactions with functionalised NPs were 
investigated, where the grafting could be used to tailor 
macrophage uptake in vitro.  
Another avenue to obtain polysaccharide NPs with polymer-
covered surfaces is via self-assembly approaches.165 For 
example, Park and coworkers grafted PEG and 5β-cholanic acid 
onto HA.166 due to the hydrophobic 5β-cholanic acid and the 
hydrophilic PEG, an amphiphilic structure was obtained that 
was capable of forming micellar particles in aqueous 
environment with PEG on the surface. The formed particles 
featured reduced uptake in the liver, prolonged blood 
circulation, and improved tumour targetability due to the PEG 
functionalisation, which was shown via in vivo cell 
internalisation studies. A similar strategy was implemented by 
various researchers in the past years to obtain PEGylated 
particles for applications in the biomedical field, e.g. DOX 
delivery,167-171 theranostic NPs to target colon cancer,172 as a 
stabiliser for deacetyl mycoepoxydience nanocrystals,173 gene 
delivery166, 174, 175 or sorafenib delivery.176 To enhance the 
stability of the formed particles, Park and coworkers introduced 
covalent crosslinking.177 In addition to PEG and 5β-cholanic acid, 
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methacrylamide units were grafted onto HA. The 
methacrylamide units were crosslinked via UV light after 
encapsulation of PTX. Sustained release of the drug was 
observed as well as improved cell internalisation leading to an 
overall enhanced therapeutic efficacy. Later on, a bioresponsive 
system was introduced (Fig. 6),178 where HA was grafted with 
PEG that was attached via a matrix metalloproteinase 9 (MMP9) 
cleavable connection (pep) as well as conjugated to ovalbumin 
(OVA) as foreign antigen. In such a way, the PEG corona 
facilitated efficient transport but was cleaved at the tumour site 
via MMP9 enabling cell uptake leading to foreign antigen 
presentation on tumour cells. As such, tumour growth was 
inhibited considerably.  
PEGylated DEX NPs were synthesised by Xiao and coworkers, 
who grafted PEG onto DEX in the first step and crosslinked via 
3,3′-dithiodipropionic acid in the second step.179 Next, DOX was 
encapsulated and drug-release studied in vitro, where the 
disulfide-based crosslinker can be cleaved via a redox stimulus. 
Pérez-Álvarez and coworkers described the formation of HA-
based nanogels crosslinked via PEG spacers in a microemulsion 
approach.180 The formed nanogels featured pH response due to 
the HA content, which was revealed by the swelling ratio at 
different pH. Wich and coworkers fabricated NPs based on 
spermine functionalised acetalated DEX.181 In a subsequent 
step, PEG or DEX were grafted onto the NP surface and their 
stability studied over time. In contrast to PEG grafting, DEX 
functionalised NPs aggregated over time. With respect to 
biological activity, PEG grafting led to attenuated particle 
binding and uptake. DEX grafting showed an opposite effect 
with enhanced passive targeting of dendritic cells and their 
stimulation. This combination is desired for vaccination avenues 
based on dendritic cells aiming to deliver an antigen and an 
adjuvant to dendritic cells at the same time in order to induce 
immune response. 
 
Fig. 6 Preparation and characterisation of the PEG-pep-HA-OVA conjugate: a) Synthetic route, b) Schematic illustration of MMP9-responsive removal of PEG from the PEG-pep-HA-
OVA and c) Zeta potential values of the PEG-pep-HA-OVA with or without MMP-9. (Reproduced with permission from 178. Copyright Elsevier, 2017.) 
Also, CS-based NPs were PEGylated in order to improve 
circulation in the body and stability. CS-coated nanocapsules 
were PEGylated by de la Fuente and coworkers.182 Initially, a 
nanoemulsion method was utilised to form CS capsules with 
lipophilic core (oleic acid). In the next step, the formed capsules 
were grafted with PEG via amide bonds. The authors showed 
that the PEG grafting hindered unspecific protein adsorption, in 
vitro studies showed low cytotoxicity and considerable 
internalisation in Vero cells. Bikiaris and coworkers synthesised 
PEG-grafted CS for the use as protein delivery system.183 For the 
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particle formation, coacervation with poly(glutamic acid) or 
ionic crosslinking with TPP was utilised. As protein to deliver, 
bovine serum albumin was encapsulated in the NPs. The 
observed release characteristics could be tailored via PEG MW, 
crosslinker content and type. Increased amounts of PEG on the 
particle surface and increased MW led to a faster release, while 
crosslinking with the small molecule TPP slowed the release 
down.  
PEGylated CS NPs for the delivery of PTX were studied by Jain 
and coworkers.184 At first PTX loaded CS NPs were formed via 
solvent evaporation method together with PVA. In the next step 
PEG was grafted onto the particles via amide formation and the 
remaining hydroxyl group at the other end of the PEG chain was 
used to conjugate transferrin. As such, the particles featured a 
drug, a stabilising corona and a cancer cell targeting moiety 
(transferrin). A considerable therapeutic effect was observed in 
vivo due to sustained release profile, greater intracellular 
uptake, promoted cell cytotoxicity and prolonged systemic 
circulation time. Hartmann and coworkers utilised CS NPs for 
gene delivery.185 At first, CS was grafted with PEG and then 
combined with unfunctionalised CS as well as small interfering 
RNA (siRNA) in slightly acidic environment. Due to the negative 
charge of siRNA and the positive charges of CS, polyplexes were 
formed, similar to the coacervation technique. The formed NPs 
featured the cargo, i.e. siRNA in the core and PEG in the shell. 
The authors studied the effect of PEGylation degree on NP 
properties. Interestingly, physicochemical properties revealed 
only minor changes, while biological activity differed 
significantly pointing towards an optimum between PEG 
stabilisation of NP transport in the body and activity of the 
carrier in gene transfection. Also, other cases of PEGylated CS-
based NPs were utilised for gene delivery, e.g. for the delivery 
of siRNA.186-188 
A nanoprecipitation avenue was utilised by Ganachaud and 
coworkers to form core-shell particles.189 A polysaccharide (PL 
or DEX) was combined with a glycopolymer, i.e. poly(N-[7-(α-D-
mannopyranosyloxy)heptyl]methacrylamide-co-glycidyl 
methacrylate), and mygliol. The polysaccharide and 
glycopolymer were dissolved in water and precipitated into 
acetone containing mygliol as a template for the core and 
crosslinked via isophorone diisocyanate. The technique enabled 
formation of mono- or multilayered glyco nanocapsules 
through simultaneous or sequential nanoprecipitation, 
respectively. The prepared nanocapsules could be loaded with 
a drug (Camptothecin), covered with biotin or magnetic 
nanoparticles attached. Due to the incorporation of DEX, 
enzymatic degradation of the capsules could be achieved via 
dextranase.  
An integrated self-assembly of polysaccharide-based double 
hydrophilic block copolymers and crosslinking was described by 
Schmidt and coworkers.190 A completely hydrophilic block 
copolymer of PL and P(PEGMA) was synthesised and the self-
assembly studied in solution showing considerable effect on the 
length of the P(PEGMA) block. In a subsequent step, PL was 
crosslinked via sodium trimetaphosphate to obtain stable NPs 
that could withstand dilution and organic solvent. In a similar 
way, the block copolymer of PL and poly(N,N-
dimethylacrylamide) was studied,91 which showed particle 
formation as well. In order to stabilise the structures, 
crosslinking was performed as well. In this case, the PL block 
was oxidised with periodate to form aldehyde functions along 
the backbone that were crosslinked via imine formation with 
cystamine. As such, NPs were synthesised that could be broken 
via pH or redox stimulus. Akiyoshi and coworkers described the 
formation of vesicles based on polymer grafted 
polysaccharides.191 PL was grafted with poly(propylene oxide) 
and the thermoresponsivity of the PPO blocks used to turn 
vesicle formation on or off. The vesicle size could be controlled 
by polymer concentration. 
The examples shown above from previous developments of 
polysaccharide NP/polymer systems describe how polymer 
chains can be attached to the surface of polysaccharide NPs and 
how a combination of polymers and polysaccharides can 
improve the applicability of polysaccharide NPs. Future 
directions certainly will consider other polymer shells and 
incorporation of polymers into polysaccharide NPs as a way to 
tailor NPs properties. However, issues such as toxicity and poor 
biodegradability caused by polymers with high molar mass limit 
the applications of these conjugated systems, which has to be 
addressed in future research.43 
4.2 Inclusion of Polysaccharide NPs into Polymer Structures 
The inclusion of a polysaccharide NP core into a polymer shell 
or matrix (Scheme 6b) has received much attention due to the 
wide applications in diverse areas.150 The synergistic effect 
resulting from combining the properties of the core and the 
shell imparts new functionality to the final obtained material.153  
Wang et al. prepared core-shell NPs which had a SNP hard core 
and a PEA outer shell to strengthen the toughness of PLA-based 
nanocomposites.153 Native starch was firstly esterified with 
acryloyl chloride and stearyl chloride to introduce 
hydrophobicity and polymerisable units. After that, a graft 
emulsion polymerisation was followed using potassium 
persulfate as the initiator. By using the “grafting from” method, 
ethyl acrylate monomers were polymerised from the surface of 
SNPs, forming the SNP-g-PEA core-shell NPs (Fig. 7a-c). Next, 
the particles were combined with PLA via melt-blending. 
Compared with pure PLA, elongation at break and notched 
impact strength were significantly improved after adding 20 
wt% SNP-g-PEA core-shell NPs (Figure 7d-e). The same authors 
also substituted PEA with poly(glycidyl methacrylate), where 
the epoxy group can act as a crosslinking point for PLA end 
groups via ring-opening.192 In a recent follow-up work, the same 
group showed even enhanced mechanical properties of 
blended PLA by implementation of two polymer layers around 
the SNPs, namely PEA and PMMA, formed via emulsion 
polymerisation.193 
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Fig. 7 a-c) TEM images of SNP-g-PEA core-shell NPs, d) stress–strain curves of PLA and 
PLA/ SNP-g-PEA core-shell NP composite (inset a shows optical photo of the samples), e) 
notched impact strengths of PLA and PLA/ SNP-g-PEA core-shell NP composite. 
(Reproduced with permission from 153. Copyright American Chemical Society, 2018.)  
By using a similar emulsion polymerisation synthesis method, 
Liu et al. synthesised SNP-based core-shell NPs with a PMA 
outer shell to improve the mechanical properties of 
poly(propylene carbonate) (PPC).152 The benefits resulting from 
the addition of 20 wt% SNP-g-PMA core-shell NPs to neat PPC 
were shown via enhanced tensile strength, increased 
toughness, and increased thermal degradation temperature for 
the PPC/ SNP-g-PMA composite. Moreover, the increased glass 
transition temperature (Tg) demonstrated that PPC/ SNP-g-PMA 
composite had higher rigidity compared to that of the neat PPC, 
providing a direction for a more comprehensive modification 
and a wider application range of PPC. Recently, SNP-g-PMA was 
utilised as compatibiliser for blends of PPC and PLA.194 The 
blends were formed via melt-blending and the 
compatibilisation was investigated via AFM, dynamic scanning 
microcalorimetry and rheology. Improved mechanical and 
thermal properties were obtained, e.g. compared to a control 
blend PPC/PLA (60/40), the elongation at break of 
PPC/PLA/SNP-g-PMA (60/40/20) was enhanced from 15% to 
272% without demoting tensile strength. Additionally, the heat 
distortion temperature of PPC/PLA/ SNP-g-PMA (60/40/20) was 
increased by 21 °C to 47 °C compared to PPC. Jiang and 
coworkers presented an avenue to enhance the mechanical 
properties of poly(propylene) (PP) via incorporation of SNPs.195 
Thermoplastic starch acetate and PP were melt-blended, 
leading to SNP formation in situ due to the addition of 
poly(ethylene octane) grafted with maleic anhydride. As such, 
higher notched impact strength and elongation at break of the 
blend material compared to the plain PP were observed. 
For the further use of the inclusion of polysaccharide NPs in 
polymer structure, Somavarapu and coworkers described a 
particle-within-particle system formed by CS-based NPs such as 
CS/TPP NPs incorporated in polymer microparticles.196 By using 
a modified W/O/W double emulsion method, Ranibizumab was 
loaded into CSNPs with a size of 17-350 nm that were entrapped 
in poly(D, L-lactide-co-glycolide) (PLGA) microparticles. The 
CSNPs loaded PLGA microparticles significantly showed 
improved Ranibizumab loading and release profile, 
demonstrating the promising future for this novel system as an 
adequate nanocarrier. Teng and coworkers presented the 
fabrication of PLGA and poly(cyclohexane-1,4-diyl acetone 
dimethylene ketal) microspheres with included HA/CS NPs. A 
double emulsion process was performed to obtain the 
composite microspheres. HA/CS NPs were loaded with siRNA as 
a treatment for rheumatoid arthritis. The deposition of siRNA 
loaded particles in the polymer matrix prevented siRNA 
degradation and improved circulation time in vivo. 
Nevertheless, the observed release was not maintained over 8 
days, which is required as rheumatoid arthritis is a chronical 
disease requiring long-term treatment. The characteristics of 
the carrier showed interesting and effective delivery properties 
and might be useful for the treatment of other diseases but 
further optimisation is needed. 
Berkland and coworkers utilised NPs based on polysaccharides 
and PLGA for hydrogel formation.197 Alginate and CS containing 
PLGA NPs were generated via coprecipitation first. In the next 
step, the oppositely charged NPs were combined to form 
hydrogels via mixing and charge-based attraction of particles. 
The gels proved to be sensitive to external force and could 
injected. Furthermore, the interactions with human umbilical 
cord mesenchymal stem cells were studied in vitro and high 
biocompatibility was indicated. 
Overall, polysaccharide NPs can lead to a considerable 
improvement in properties when combined with a polymer 
matrix, e.g. mechanical properties but also cargo encapsulation 
and release. In addition, polysaccharide NPs act as filler material 
from renewable resources, which is another advantage. More 
research on polysaccharide/polymer systems is essential to 
promote them for broader application areas and overcome the 
challenges when using them. 
4.3 Aqueous two-phase system templated polysaccharide 
microparticles 
ATPS are formed from specific mixtures of two hydrophilic 
polymers or salts at elevated concentration.60, 61 A commonly 
used system is the combination of PEG and DEX. These systems 
feature a completely water-based environment and very low 
surface tensions between the two phases.7, 198 In recent years, 
ATPS have been utilised frequently for the separation of 
biomacromolecules as well as nanoparticles199-201 or as 
environment for enzymatic catalysis.202 In addition to 
macroscopic ATPS, dispersed systems, i.e. water-in-water 
emulsions, have been investigated as well135, 136 that can be 
employed as template for the formation of microparticles in 
aqueous environment.203 Huck and coworkers synthesised 
microparticles via microfluidics with droplets containing the 
ATPS from DEX and poly(ethylene glycol) diacrylate (PEGDA) 
that were formed in oil.203 The diacrylate phase was 
photopolymerised to obtain stable particles. In such a way, DEX 
core/PEGDA shell particles were produced and the particle 
shape could be tailored via the DEX/PEGDA ratio, e.g. core/shell 
or particles with socket. Another crosslinking technique was 
explored by Ono and coworkers, namely amide formation via 
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active esters and amines (Fig. 8).204 In a microfluidic avenue, 
droplets of PEG/DEX were formed in oil. After phase separation, 
the PEG phase settled as the shell of the aqueous droplets. 
Notably, the PEG solution was fed into the system via two 
streams as two PEG species were employed, i.e. tetra-arm PEG 
with either NH2 or N-hydroxy succinimide ester functionality 
that crosslinked immediately after phase separation. In such a 
way, crosslinking was performed directly without light or other 
stimuli, revealing PEG/DEX capsules.  
 
Fig. 8 Formation of PEG/DEX capsules via ATPS templating in a microfluidic system. 
(Reproduced with permission from 204. Copyright American Chemical Society, 2019.) 
The fabrication of Janus particles was described by Shum and 
coworkers.205 Here, also microfluidics were utilised to form 
droplets containing PEG and DEX in an oil. In order to form half-
spherical particles, the partitioning behaviour of agarose in the 
ATPS was exploited that preferably enriches in the PEG phase. 
As agarose solidifies at low temperatures, the PEG phase was 
stabilised against dissolution in water, while the DEX phase 
dissolved revealing PEG half spheres at temperatures below 17 
°C. PNIPAM/alginate based microparticles were presented by 
Arkedani and coworkers, who used Ba2+ for ionic crosslinking of 
alginate and microfluidics for droplet formation and 
thermoresponsive PNIPAM for templating.206 A completely 
water-based approach was introduced by van Esch and 
coworkers.207 Three streams were employed in microfluidics, 
i.e. a PEG-containing stream for the core, a DEX-containing 
stream for the shell and a PEG-containing stream as continuous 
phase. PEG-in-DEX droplets were formed in a PEG-solution and 
the DEX phase crosslinked via photo-induced thiol-yne reaction. 
As such, permeable capsules were synthesised in a completely 
aqueous system. 
ATPS provide a useful avenue to template the formation of 
polysaccharide based microparticles in a completely water-
based environment. As such, organic solvents can be excluded, 
which is highly interesting for bio-related applications.  
5. Applications of Polysaccharide Nanoparticles 
In various areas of research and application, nano-sized delivery 
systems based on polysaccharide NPs have been widely used in 
transporting biomedical “cargoes”, for example, drugs, genes, 
polypeptides, proteins, vaccines or nucleic acids. Moreover, 
polysaccharide NPs can be used in other areas of applications 
such as Pickering emulsion stabilisers/emulsifiers and as 
reinforcing agents in various materials due to their 
environmental-friendly properties. For instance, when 
polysaccharide NPs are used to enhance other biodegradable 
and renewable polymers, efficient and eco-friendly materials 
with adequate thermo-mechanical properties can be obtained, 
which is crucial for the development of materials without any 
environmental issues and overcoming the disadvantages of the 
original material, e.g. fragility.19, 56  
For example, Iijima and coworkers utilised polysaccharide NPs 
as precursors for polysaccharide films that were studied with 
respect to interactions with biological cells.208 CS was combined 
with anionic polysaccharides to form NPs and subsequently the 
dispersions were cast into molds and dried at elevated 
temperature to obtain particle-based films. Depending on the 
anionic polysaccharide type cell adhesion could be tailored. 
Practical applications of polysaccharide NPs in the fields of 
nanomedicine, cosmetics, and food systems are summarised in 
the following sections and discussed with respect to their 
suitability and required properties for the respective 
application. 
5.1 Polysaccharide Nanoparticles in Nanomedicine 
In biomedicine and biomaterials engineering, polysaccharide 
NPs have significant advantages and potential applications due 
to their biocompatibility and biodegradability.19, 209 Especially in 
the field of nanomedicine, polysaccharide NPs can be exploited 
due to their favourable properties in biological systems, e.g. due 
to their mucoadhesive properties and cell uptake.210, 211 As such, 
applications like drug-delivery and tissue engineering are 
discussed frequently but also other therapeutic developments 
have been presented in recent years. For example, Park and 
coworkers described the utilisation of CS-based nanoparticles 
for photodynamic therapy.212 There, the photosensitiser 
Pheophorbide A was conjugated to CS via a reactive oxygen 
species sensitive thioketal linker. The amphiphilic CS-conjugate 
self-assembled into NPs in aqueous environment leading to a 
self-quenching of the photosensitiser. The presence of reactive 
oxygen species in tumour environment resulted in thioketal 
bond cleavage and release of the photosensitiser. The 
photosensitiser was activated by near infrared irradiation in 
turn with a toxic effect. Another approach to photodynamic 
therapy was described by Wich and coworkers (Figure 8).213 A 
fully polysaccharide-based block copolymer consisting of DEX 
and acetalated DEX blocks was synthesised via a copper free 
click reaction based on thiol exchange leading to disulfide 
connected blocks. Next, micelles were formed and 
phthalocyanine zinc as photosensitiser encapsulated, where the 
block copolymer acted as surfactant for the zinc complex. 
Delivery of the payload was investigated in vitro, where the 
block copolymer stabilised the photosensitiser to increase 
bioavailability. Upon irradiation with NIR light, a strong 
concentration dependent toxic effect was observed. It should 
be mentioned that the disulfide block connection introduced 
redox responsive degradation of the micellar NPs. In a 
subsequent contribution, DEX NPs were conjugated with folic 
acid to improve specific uptake of the photosensitiser into 
cancer cells (Fig. 9).214 
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Fig. 9 Mechanism of folic acid targeted photodynamic therapy: DEX NPs loaded with 
tetraphenylporphyrin are taken up via endocytosis and release the photosensitiser for 
phototoxic effect.214 (Licensed under CC-BY 2019) 
Alonso and coworkers studied CS/DS or CS/HA coacervate NPs 
loaded with an HIV peptide antigen candidate, i.e. HIV protease 
cleavage site 5 peptide (PCS5).215 The authors investigated 
various factors in their NPs and the effect on immune response. 
For example, the attachment of the antigen via ionic 
interactions, cleavable or non-cleavable conjugation was 
investigated as well as the presence of immunomodulatory 
molecules such as poly(inosinic acid):poly(cytidylic acid) 
(poly(I:C)). All NP formulations showed a generation of antibody 
responses. Overall, NPs with PCS5 conjugation and poly(I:C) 
incorporation featured the strongest activation of antigen-
presenting cells. Sacco and coworkers investigated the effect of 
CS acetylation on the immune cell response.125 CS was 
combined with short HA in a coacervate formation for the 
synthesis of NPs. The particles were studied regarding stability 
at different pH and osmolarity, where only type of acetylated CS 
showed stability over a broad range of conditions. In the 
subsequent immune response studies, the stable formulation 
induced minor immunogenic response while less stable 
compositions induced tumour necrosis factor-α production by 
macrophages. The study revealed that the 
hydrophilic/hydrophobic balance of polysaccharides is major 
factor in interactions with biological systems. 
Two most relevant applications of polysaccharide nanoparticles 
in biomedicine, i.e. drug/gene delivery and tissue engineering, 
are discussed in detail below. 
5.1.1 Polysaccharide NPs for Drug/Gene Delivery 
In recent years, the mechanism of the circulation of polymeric 
drug/gene-loaded NPs in human bodies has been broadly 
investigated. After the injection into the body, drug/gene-
loaded NPs cross the epithelial barriers and circulate in the 
blood vessels before reaching the target site. The drug 
accumulation in targeting sites (e.g. tumours) usually results 
from the enhanced permeation and retention (EPR) effect, 
which is based on eased penetration of NPs into pathological 
tissues due to more accessible fenestrations in the tissue.32 The 
EPR effect is a unique phenomenon of pathological tissues such 
as solid tumours related to their anatomical and 
pathophysiological differences from normal tissues. Moreover, 
potential severe adverse effects to healthy tissue caused by 
systemically-delivered active drugs can be prevented by using 
drug-loaded NPs via the EPR effect.58, 216  
Furthermore, polysaccharide NPs were utilised to improve the 
solubility of poorly water-soluble drugs, transport the active 
drug molecules to a targeted pathological site, and release 
drugs controllably and sustainably for drug/gene delivery.19 
Also, various useful theranostic systems based on 
polysaccharide NPs were summarised by Lee and coworkers, 
e.g. fluorescence imaging and drug delivery, magnetic 
resonance imaging and drug delivery or near-infrared 
fluorescence imaging and drug delivery.58  
The polysaccharides discussed above (Section 2) can effectively 
be used to develop suitable delivery systems. Aminabhavi and 
coworkers described diverse pharmaceutical applications of CS 
particulate systems, including cancer therapy, gene delivery, 
mucosal delivery, topical delivery, ocular delivery and colon 
targeted drug delivery.87 Yameen’s group developed novel 
colonic enzyme-responsive DEX based oligoester crosslinked 
NPs for the controlled release of an anticancer drug, 5-
fluorouracil (5-FU).217 The results obtained from their study 
showed that 5-FU was effectively encapsulated in the DEXNPs 
(Fig. 10), and the synthesised DEXNPs maintained their stability 
at pH conditions representative of specific in vivo environments 
(e.g. stomach, small intestine, and colon). Moreover, as 
reported by the studies of release kinetics and colon cancer cell 
viability, it was found that 75% (± 4) of the encapsulated 5-FU 
was released in 12 h in the presence of dextrananse and the 
used HCT116 cell displayed a substantial cell viability decrease. 
These results demonstrated the potential applications of the 
studied DEXNPs as a specific 5-FU delivery system in response 
to the dextranase enzyme. In addition to the DOX-loaded 
HANPs discussed in Section 3 and Section 4, other 
polysaccharides and their derivatives were also investigated by 
different research groups for their utilisation in DOX delivery. 
Based on their studies, CSNPs,48, 87, 147 CLNPs,218, 219 SNPs,220, 221 
and DEXNPs 63, 222, 223 proved to be potential nanocarriers for 
antitumour drugs such as DOX in order to enhance their 
therapeutic effects. 
  
Fig. 10 a) Schematic overview for nanoprecipitation assisted fabrication of DEXNPs in the 
presence of 5-FU, as well as depiction of dextranase responsive drug release, b) SEM 
image of 5-FU loaded DEXNPs, c) release kinetics of DEXNPs at simulated pH 1.2, PBS 6.8, 
PBS 7.4 & dextranase (15 U/ml) and d) cytotoxicity of DEXNPs against HCT 116 colon 
cancer cell line after 1 h of exposure of DNPs to dextranase. (Reproduced with 
permission from 217. Copyright Elsevier, 2020.) 
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Some polymer NPs with polysaccharide shellhave also attracted 
attention to be used as adequate nanocarriers. For 
encapsulating and protecting Astaxanthin, Xu and coworkers 
utilised CS oligosaccharides to form a cationic hydrophilic shell 
around the anionic hydrophobic PLGA NPs.149 The results of 
their work showed that the core-shell NPs formed had 
improved water solubility and stability compared to the PLGA 
NPs without a CS oligosaccharide shell, making the developed 
NPs suitable for their future applications in transporting 
hydrophobic nutraceuticals and drugs. A polysaccharide NP 
based on DS/CS for the delivery of insulin was described by 
Neufeld and coworkers.224 The NPs were designed for oral 
dosage and provide improved intestinal absorption. An 
improved performance compared to oral insulin solution 
(revealing 2−3-fold improvement of oral relative 
pharmacological availability). Heinze and coworkers described 
the attachment of a histone deacetylase inhibitor into CL or 
DEX-based NPs, i.e. valproic acid.225 The acid was attached via 
esterification and NPs formed via nanoprecipitation or emulsion 
method. The formed particles could be used for valproate 
release via enzymatic cleavage of the ester bond, which was 
studied in vitro and in shell-less Hen’s egg tests. Overall, the 
nanocarriers revealed good biocompatibility. An alginate-based 
system for the delivery of NO and Ag NPs was described by 
Seabra and coworkers.226 Alginate NPs were synthesised via 
gelation with Ca2+ and a precipitation. Furthermore, Ag NPs 
synthesised from AgNO3 and tea extract and mercaptosuccinic 
acid (a NO acceptor) were encapsulated into the alginate NPs. 
The particles could be loaded with NO via nitrosation of 
mercaptosuccinic acid and utilised subsequently for 
antibacterial purpose. The particles showed antibacterial 
activity against three bacteria strains indicating a synergistic 
effect of NO release and Ag NPs, while not being toxic to Vero 
cells.  
Gene delivery is a frequently investigated application of 
polysaccharide NPs.227-229 Especially, CS complexation with 
siRNA or DNA for gene delivery has been studied frequently.230-
232 For example, Leong and coworkers synthesised CS-based 
nanoparticles with DNA loading.233 Thus, CS/DNA NPs were 
formed via a coacervation process. The particles were 
PEGylated and conjugated with transferrin to enhance stability 
and cell uptake. Minimal cytotoxicity was observed and gene 
transfection in various cell types e.g. HEK293, HeLa or IB-3-1, 
which could be tailored via the surface functionalisation. 
Fréchet and coworkers described gene delivery based on DEX 
NPs.234, 235 DEX was partially oxidised via periodate, acetalated 
and conjugated with spermine by reductive amination. The 
carrier particles were generated via a double emulsion 
technique and directly loaded with siRNA. The cationic 
spermine functionalisation acted as a handle to complex with 
siRNA for high loading efficiency. Gene transfection was studied 
via knockdown of luciferase expression in HeLa cells in vitro. As 
the spermine/siRNA interaction is sensitive to pH, selective 
release was observed after internalisation in the cell only.  
A NP based on PL was described by Letourneur and coworkers 
(Fig. 11).236 Cationic modified PL was combined with Fucoidan 
in a coacervation process to form NPs and microRNA adsorbed 
at the surface. The system promoted microRNA delivery inside 
cells and selectively targeted towards cells with P-selectin over-
expression at the surface of activated platelets and endothelial 
cells in atherothrombotic-related diseases. Amiji and coworkers 
studied HA-based gene delivery.237 HA was grafted with hexyl 
chains to introduce hydrophobicity, PEG to enhance particle 
stability and poly(ethylene imine) (PEI) to facilitate interaction 
with siRNA. Tumour necrosis factor-α-specific siRNA was 
encapsulated and the uptake as well as down regulation of 
tumour necrosis factor-α in macrophages observed. As such, an 
improved survival rate was observed in the mouse model. Gene 
carriers based on alginate/Ca2+ complexation have been 
described as well. Peng and coworkers formed alginate NPs via 
W/O microemulsion and crosslinking via Ca2+.80 In order to test 
gene delivery, GFP-encoding plasmids were encapsulated and 
the degree of endocytosis by NIH 3T3 cells was investigated. Ca-
alginate NPs with an average size around 80 nm in diameter 
were very efficient gene carriers compared to plasmid DNA 
(pDNA) condensed by PEI. 
NPs from CRG for drug-delivery purposes have been described 
as well, where frequently a complexation with CS was used for 
NP stabilisation. Grenha et al. described the formation of NPs 
from -CRG and CS via a complex coacervation process.238 
Particles in a size range from 400 to 700 nm were described with 
adjustable properties according to the ration of the two 
polysaccharides. In the next step, loading with OVA as well as 
release was probed. A sustained and controlled release of OVA 
over three weeks was observed. A similar structure was 
described by Chung and coworkers, who used -CRG and CS-
based NPs for the loading and delivery of insulin via oral 
administration.239 Abdelghany et al. produced -CRG and CS-
based NPs for tuberculosis treatment via ethionamide was 
encapsulation.240 The CRG content was varied to study the 
effect on particle size, zeta potential and drug release. In 
particular, it was found that CRG stabilised the particles and 
enhanced ethionamide entrapment. A sustained release was 
observed and considerable antimycobacterial activity. A CRG-
based capsule was described by Tánori and coworkers, who 
utilised an emulsion process to form capsules from -CRG and 
CS.241 At first olive oil nano emulsion droplets were formed and 
-CRG/CS deposited at the interface via layer-by-layer 
assembly. The oi droplets were loaded with the lipophilic anti-
inflammatory drug Diflunisal and the release studied. A zero-
order release profile was observed for three- and four-layer 
systems, while first order release kinetics were observed for one 
and two layers as well as a Fickian diffusion for emulsion 
droplets without polysaccharide coating. 
To enhance the cellular delivery of genetic materials, NPs with 
polysaccharide coating were described as well, for example HA-
PEI, HA-PEG, and HA-PEI/HA-PEG were synthesised by Amiji and 
coworkers in order to encapsulate pDNA.155 The negatively 
charged HA formed the hydrophilic shell of the NPs, and the 
combination of HA, PEI and PEG has a considerable effect on 
gene expression results because of the ability of 
HA−PEI/HA−PEG NPs to protect pDNA from the environment. In 
addition, the appropriate pDNA accessibility of HA−PEI/HA−PEG 
NPs could result in controlled release of pDNA and improved 
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transfection in cells, which might be useful for the delivery of 
genetic material for cancer therapy. Liu et al. designed a novel 
core-shell nanoparticle system based on PL and poly(β-amino) 
ester (PBAE) for the codelivery of plasmid DNA expressing green 
fluorescent protein (pEGFP) and the model chemotherapy 
agent Methotrexate (MTX).156 The MTX-PL/PBAE/pEGFP NPs 
prepared had a PL shell and a PBAE/pEGFP core. Also, they were 
found to exhibit a strong hepatoma-targeting property at both 
cellular and animal levels, indicating its potential for 
combination of chemotherapy and gene therapy. Although 
coating drug/gene-loaded hydrophobic polymer NPs with a 
hydrophilic polysaccharide shell can improve their stability and 
water solubility for improved delivery, information of the safety 
and efficacy of the polysaccharide/polymer systems still 
requires more research.149  
 
 
Fig. 11 Formation of NH2-PL/Fucoidan coacervate NPs and loading with microRNA (miRNA) (left), particle characterisation via SEM and pH response (top) and mean fluorescence 
intensity (MFI) of fluorescein amidite (FAM) measured by flow cytometry analysis revealing the uptake in human umbilical vein endothelial cells (HUVECs) (right). (Reproduced with 
permission from 236. Copyright Elsevier, 2021.) 
Drug/gene delivery systems based on polysaccharide NPs have 
great potential in the treatment of cancer and other diseases 
such as diabetes. However, further study is crucial to overcome 
several challenges in their use. For example, the drawbacks 
resulting from the reliance on the EPR effect for passive 
targeting during the drug/gene delivery: Heterogenicity of the 
EPR effect caused by factors such as variations in NP size can 
result in uncertainty in delivery efficiency. Moreover, burst 
release and compromised mechanical properties caused by 
incomplete degradation of polysaccharide NPs is an issue that 
should not be ignored.242 Thus, ongoing development of 
targeted delivery systems is required to improve drug/gene 
delivery efficiency. 
5.1.2 Polysaccharide NPs for Tissue Engineering 
Tissue engineering aims at developing biological substitutes 
that restore, maintain, or improve tissue function by using the 
principles of engineering in life sciences. In tissue engineering, 
cells and cell carriers are two primary components, which play 
significant roles in developing the biological substitutes. The cell 
carriers are usually referred to as scaffolds, and their functions 
involve delivering cells to a desirable area and inducing local 
tissue regeneration, as barriers to protect transplanted cells or 
tissues from host immune attack, or as reactors to stimulate 
host cell recruitment, homing, and differentiation.37, 243 Tissue 
engineering covers the generation of scaffolds, hydrogels, and 
particulate systems from biocompatible polymers to transport 
growth factors, which are soluble secreted proteins important 
for tissue regeneration.49, 244 The efficiency of tissue engineering 
is improved by controlled release of therapeutic factors to 
specific sites, which is thought as a special case of drug 
delivery.32 During the delivery and release process of protein-
based growth factors, polysaccharide-based micro-
/nanoparticles are a suitable carrier material because they can 
protect the growth factors, give a versatile release profile, and 
reduce the possibility of the side effects.242  
Mandal and coworkers prepared dual growth factor loaded 
CSNPs by using epidermal growth factor (EGF), fibroblast 
growth factor (FGF) and CS.245 The increased proliferation of 
fibroblasts in vitro demonstrated the successful delivery of 
growth factors from CSNP. Moreover, non-toxicity of growth 
factors loaded CSNPs and controlled release were observed, 
and the attachment and growth of fibroblast in EGF/FGF-CSNP 
system were significantly improved. These results indicated the 
promising utilisation of this dual growth factors loaded 
nanoparticle system in tissue engineering area. 
In the work of Alonso and coworkers, CS/HA based NPs were 
synthesised by using TPP ionic gelation for transporting vascular 
endothelial growth factor (VEGF) and platelet derived growth 
factor (PDGF-BB).57 The results demonstrated that the CS/HA 
based nanocarriers were stable in biological media without any 
cytotoxicity. According to their in vitro release studies, PDGF-BB 
could be released from CS/HA NPs sustainably in one week, 
while the release of VEGF was uncontrollable. This report 
already showed the future of injectable PDGF-BB loaded CS/HA 
nanoparticle system in the fields of tissue engineering and 
treating ischemia-related diseases but further research is 
needed in the control of growth factor release. Wu and 
coworkers described a novel DEX- and gelatin-based 
nanoparticle system (DGNPs) for encapsulating and 
transporting the growth factor bone morphogenetic protein 
(BMP).246 The mono-dispersed DGNPs formed had a mean 
diameter of about 54 nm and good swelling and degradation 
properties in the target media. According to their in vitro 
release studies, more than 90% of the loaded BMP was 
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maintained for more than 12 days and released in a sustained 
manner. These positive results proved that the formed DGNPs 
have the potential to be biodegradable and biocompatible 
carriers for protein-based growth factors. Goncalves and 
coworkers presented NPs based on CS and poly(γ-glutamic acid) 
with diclofenac as non-steroidal anti-inflammatory drug for the 
treatment of degenerated intervertebral disks.247 
 
Fig. 12 Schematic representation of a cross-junction microfluidic device used to 
hydrodynamically focus the Chitosan–dexamethasone flow using a sheath flow of 
adenosine triphosphate-containing water for the preparation of CS-based NPs and their 
use in cell growth. (Reproduced with permission from 248. Copyright Elsevier, 2015.) 
Tayebi and coworkers described a microfluidic avenue for the 
preparation of CS/dexamethasone NPs that were utilised as 
adjuvants in cell growth (Fig. 12).248 The effect of the adenosine 
triphosphate-crosslinked particles on the osteogenic 
differentiation of mesenchymal stem cells was studied. Due to 
the tailored size of the NPs improved differentiation was 
observed via enhanced dexamethasone release. 
It should be noted that polysaccharide NPs with hydrophilic 
properties can be utilised as adequate growth factor 
nanocarriers, but several issues (e.g. safety, cost, efficacy) need 
to be addressed for development of successful growth factor 
therapies. The preclinical results from in vitro cellular study and 
in vivo animal model may not perfectly simulate the physiology 
and pathophysiology in humans, which has to be studied 
thoroughly to enable future applications.242, 244 Thus, further 
studies are required to enhance the control over polysaccharide 
NP-governed tissue growth processes. 
5.2 Polysaccharide Nanoparticles in Cosmetics 
Cosmetics are consumer products to be placed in contact with 
the external parts of the human body, with teeth or the mucous 
membranes of the oral cavity. The primary utilisations of 
cosmetics include cleaning, change of appearance, and body 
odour correction.249 The use of polysaccharide-based NPs is a 
specific branch area of applying nanotechnology in cosmetics. 
Many researchers have investigated the applications of 
polysaccharide-based NPs in improving the properties of 
cosmetic products, for instance, using them as cosmetic 
ingredients to stabilise Pickering emulsions or deliver useful 
substances.10  
5.2.1 Polysaccharide NPs for Pickering Emulsion Stabilisation 
Emulsions are widely used in various fields such as 
pharmaceutics, drug delivery or food industry.250 To form 
various cosmetic and personal care products such as 
antiperspirants, deodorants, and anti-aging products, 
emulsions are also frequently used.251 As introduced in Section 
3, an emulsion is a dispersion of two immiscible liquids. In the 
absence of an adequate interfacial stabiliser, the formed 
emulsions are unstable and tend to undergo phase separation, 
causing creaming in the emulsion. To solve this issue, 
surfactants and solid NPs are used because they can reduce the 
interfacial tension between the two phases and improve 
emulsion stability.252, 253  
Emulsions stabilised with solid NPs are also referred to as 
Pickering emulsions (Scheme 8). Though surfactants can 
enhance both the kinetic and thermodynamic stability of the 
emulsions, their toxicity, high cost, and impractical recovery 
lead to issues.251, 252 However, solid NPs such as polysaccharide 
NPs used in Pickering emulsions can be environment-friendly 
and biologically compatible. Besides, Pickering emulsions can 
impart improved stability against coalescence. These 
advantages cause that Pickering emulsions can replace the 
surfactant stabilised emulsion to produce long-term stabilised 
emulsions to be applied in cosmetics.251, 252, 254 In the review of 
Yuan and coworkers, various types of solid particles utilised in 
forming Pickering emulsions were listed and discussed in 
detail.250 Nanoscale particles derived from nature 
polysaccharides such as CH nanocrystals,19 CL nanocrystals,255, 
256 and starch nanocrystals256-258 were found to be potential 
Pickering emulsion stabilisers due to their superior performance 
in various areas. 
 
Scheme 8 a) Structure of a polysaccharide NP stabilised Pickering emulsion and b) 
Pickering emulsion with cargo loaded droplets. 
Biodegradable and antibacterial CS is widely used in 
cosmetics,259 and CSNPs have been investigated by many 
researchers for their utilisation in stabilising Pickering emulsion. 
Tong’s group described a simple, straightforward reversible, 
and long-term stable (>2 months) Pickering emulsion system 
based on CS.260 At high pH conditions (pH>6), CS is water-
insoluble and the CSNPs were formed in situ by aggregation. 
These CS aggregates adsorbed at the interface of oil and water 
to stabilise the O/W emulsions, forming an excellent stabilised 
Pickering emulsion system. While at low pH conditions (pH<6), 
CS is water-soluble and the demulsification phenomenon 
occurred. The results obtained from this study demonstrated 
that CS is a practical pH-sensitive emulsifier, and the Pickering 




















































































































ARTICLE Journal Name 
22 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
emulsions formed by CS could be useful to fabricate a broad 
range of reversible emulsion systems. 
The abundant, low-cost, and biodegradable starch also has 
potential applications in stabilising cosmetic Pickering 
emulsions.261, 262 However, the broad size distribution of starch 
particles negatively affects its performance as an emulsifier.250 
Therefore, various modifications (e.g. hydrophobic 
modification) of starch have been investigated to increase the 
possibility of SNPs to adsorb at the oil-water interface during 
emulsification.261 Wang and coworkers described a novel 
particulate emulsifier based on starch-acetic anhydride-phthalic 
anhydride nanospheres for undecanol- and glyceryl 
trioctanoate-water emulsions.263, 264 According to the results 
from confocal laser scanning microscopy, the nanospheres were 
adsorbed at the liquid interface, forming a dense film around 
the dispersed droplets. Besides, it was found that salt addition 
could cause emulsion coalescence, and the O/W emulsions 
could be inverted to W/O emulsions by varying the water/oil 
volume ratio and pH of aqueous dispersion, respectively. These 
results demonstrated the promising future of using 
biocompatible SNPs as practical Pickering emulsions stabilisers. 
As the properties of starch depend on its origin, the possibilities 
of native starches extracted from different sources such as taro, 
wheat, waxy maize, rice, and potato as Pickering emulsions 
stabilisers were also studied by other groups.265, 266 For instance, 
Sun’s group prepared four different types of SNPs to stabilise 
the soybean O/W emulsion system.261 Their results showed that 
the SNPs with near-neutral wettability were synthesised from 
sweet potato, corn, and tapioca. The near-neutral wettability 
promoted the adsorption of SNPs at the oil-water interface and 
the Pickering emulsion stabilisation. In addition, it was also 
found that the SNPs size could affect the stability of the 
emulsion, the corn-derived SNPs were less stable than the other 
two because of the smaller particle size and the caused deviated 
contact angle from 90°. 
A combination of NPs derived from CS and starch for the 
formation of Pickering emulsions was described by Matos and 
coworkers.267 Due to their considerable difference in size (nm 
vs. micron), the order of stabiliser addition had a profound 
effect on the obtained droplet sizes of oil in water. When CS 
particles are added first, both particle types perform 
stabilisation, while in the case of simultaneous addition, 
stabilisation is predominantly due to the larger starch NP 
addition that displace CS particles. Wang and coworkers 
employed starch NPs as Pickering stabiliser for the fabrication 
of microgels.268 At first starch was hydrophobised via butyl 
glycidyl ether and palmitate, then NPs were formed via 
nanoprecipitation. In the next step, an inverse Pickering 
emulsion was formed with n-hexane as the continuous phase 
and an aqueous solution of acrylamide, acrylic acid and initiator 
as dispersed phase. After homogenisation the polymerisation 
was started at 30 °C and well-defined microgels decorated with 
starch NPs were obtained. Héroguez and coworkers fabricated 
Pickering emulsions of medium chain triglyceride or dodecane 
in water via acetalated DEX NPs (Fig. 13).269 The acetalated DEX 
NPs were formed via nanoprecipitation and had a diameter 
around 200 nm. As acetals can be hydrolysed under acidic 
conditions the particles featured pH responsivity, leading to 
destabilisation of the emulsion after hydrolysis. 
 
Fig. 13 Cryo-SEM image of the surface of a dodecane droplet in water stabilised by 
acetalated DEX NPs. (Reproduced with permission from 269. Copyright American 
Chemical Society, 2020.) 
In summary, applying polysaccharide NPs in Pickering emulsions 
can reduce the tendency of emulsion coalescence and 
introduce high stability, biocompatibility, and non-toxicity, 
which will provide support to developing stabilised Pickering 
emulsions used in different areas such as cosmetics. 
5.2.2 Polysaccharide NPs for Delivery of Cosmetic Ingredients 
Polysaccharide NPs such as CSNPs, HANPs, and SNPs can also be 
introduced as nanocarriers in cosmetical care products (for hair 
or body care) due to their biodegradability. In many cases, 
bioactive substances in cosmetic formulations such as vitamins 
are not stable, e.g. they are sensitive to temperature, pH, light 
and oxidation. Therefore, encapsulation and protection are 
required to avoid unwanted degradation and to ensure target-
specific release.270  
Kim et al. successfully encapsulated a cosmetical vitamin A 
alcohol, e.g. retinol, into CSNPs for cosmetic and 
pharmaceutical applications.271, 272 As such, the solubility issues 
of retinol in water was solved by incorporating it into CSNPs, 
and the study showed that the retinol water solubility was 
increased more than 1600-fold. Inspired by this, Harris et al. 
prepared CS hydrochloride (HCS)-TPP based NPs for the 
encapsulation of yerba mate (Ilex paraguariensis (ILE)) 
extract.273 The results demonstrated that the CSNPs involved 
encapsulation method is a promising technique to prepare a 
vehicle for antioxidants protection, e.g. ILE-polyphenols, which 
are significant ingredients in the nutraceutical and cosmetic 
area. 
The polysaccharide NPs stabilised Pickering emulsion system 
discussed in Section 5.2.1 can also be used to encapsulate 
bioactive substances in cosmetics (Scheme 8b). Curcumin has 
been considered as a cosmetic ingredient due to its antioxidant 
and anti-inflammatory effects on the skin. The efficiency of 
curcumin can be enhanced by nanoencapsulation, which 
provides improved skin penetration and retention.274 Several 
researchers have investigated the utilisation of CSNPs stabilised 
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Pickering emulsion as a curcumin delivery system. For instance, 
Li and coworkers encapsulated curcumin in CS-TPP NPs 
stabilised medium chain triglyceride-water Pickering emulsion 
system.50 According to the results of stability and in vitro release 
studies, the half-time for the encapsulated curcumin 
degradation was about 120 hours, and a sustained curcumin 
release was obtained. It was also found that the stabilised 
Pickering emulsion system had high stability against pH change 
and salts, indicating that the CS-TPP NPs stabilised Pickering 
emulsion could be an adequate delivery system for bioactive 
compounds such as curcumin. 
 
Fig. 14 CH/HA NPs have the capacity to disturb the stratum corneum lamellae 
organisation, increasing the skin penetrability of the active ingredients entrapped, e.g. 
polyphenols, lutein or -carotene.275 (Licensed under CC-BY 2014.) 
The utilisation of CH Nanofibril-HA based NPs (CH/HA NPs) as a 
cosmetic formulation to deliver active ingredients in skin care 
was discussed by Morganti et al (Fig. 14).275 In their study, lutein 
was used as an example of the active ingredient to be delivered. 
In vitro studies were conducted to evaluate the anti-aging 
activity of the CH/HA NPs by measuring antioxidant capacity, 
anti-collagenase activity, and metalloproteinase and pro-
inflammatory release. Also, a 60-days double-blind vehicle-
controlled study on a subject group of 60 persons affected by 
photo-aging was carried out to show the in vivo efficacy of the 
CH/HA NPs. CH/HA NPs were demonstrated to be capable to 
easily loaded active ingredients, facilitate penetration through 
the skin layers, and increase their effectiveness and safety as an 
anti-aging agent. Moreover, the development of biodegradable 
and biocompatible CH/HA NPs for the targeted delivery of 
specific ingredients could improve skin aging activity and 
accelerate wound healing processes.  
Polysaccharide NP-based delivery systems have not only been 
utilised in skin care, but also in hair care. Gelfuso and coworkers 
developed Minoxidil sulphate (MXS)-loaded CSNPs for targeted 
delivery to hair follicles.276 MXS plays a very significant role in 
treating male and female androgenetic (or pattern) alopecia, 
however, there are many limitations when using MXS alone, 
such as low Minoxidil water solubility, high irritation caused by 
continuous use of the market formulations, and the side effects 
due to its potent antihypertensive activity. Thus, the targeted 
delivery of Minoxidil to hair follicles is a significant topic in 
cosmetics.249 In the work of Gelfuso and coworkers, the MXS 
loaded CSNPs prepared could accumulate into the hair follicles 
and release the MXS in a sustained manner. Moreover, there 
was a two-fold MXS increase in the hair follicles when compared 
to a control solution, demonstrating that the MXS loaded CSNPs 
are easy and promising delivery systems to improve the topical 
treatment of alopecia. 
Considerable advantages of polysaccharide NPs based cosmetic 
delivery systems are their remarkable biodegradability, 
biocompatibility, and high stability. However, both fungal and 
bacterial degradation can be a drawback in cosmetic 
formulations using biodegradable polymers, which has to be 
addressed in future research directions. In addition, it is 
necessary to put more emphasis on regulatory status and 
production processes to reduce the cost and pollution for 
further advancement.270, 275  
5.3 Polysaccharide Nanoparticles in Food Systems 
In food and agricultural systems, the applications of 
nanotechnology are growing rapidly. Nanoscale control may 
lead to the modification and improvement of various 
macroscale characteristics, such as processability, stability, 
shelf-life, taste, texture, and other sensory attributes, which 
enables the design of healthier, tastier, and safer foods by 
manipulating food ingredients more precisely.277, 278 As such, 
there are many potential applications for polysaccharide-based 
NPs to be used in food and agricultural systems. Some examples 
of how polysaccharide NPs can be used in food packaging and 
food delivery systems will be discussed below. 
5.3.1 Polysaccharide NPs for Food Packaging 
Packaging provides protection against physicochemical 
damages during storage or transportation of food, improves 
shelf-life, and facilitates handling. Therefore, it is vital in food 
industry. There are two advanced types of packaging in food 
industry, which are smart/intelligent packaging and active 
packaging. Intelligent packaging displays changes in food 
characteristics over time due to the existence of tailored 
materials in the matrix acting as an indicator. For example, 
smart colour-changing temperature sensitive NPs can be used 
as nano-indicators in the control of food storage. Because these 
nano-indicators can show colour changes when the food 
products are heated above or cooled below a reference critical 
temperature, the potential food spoilage can be indicated. 
Active packaging mainly provides advantages such as inhibiting 
microbial growth or preventing oxidation- and UV-induced 
damage to food products. For example, active packaging can be 
produced by adding antimicrobial, antioxidant and 
photoprotective nanoparticle additives into the packaging 
structure.279, 280  
A typical example of developing nanoparticle packaging 
additives, which simultaneously have intelligent and active 
properties was described in the study of Kritchenkov et al.280 
Their work was on the basis of the preparation and 
characterisation of polysaccharide based NPs which had a 
PEG/methylcellulose (MC) coreincluding anthocyanidin and 
sodium acetate, and a CS/gallotannin-based shell. The PEG/MC 
core and anthocyanidin/sodium acetate acted as the smart part 
of the NPs. As such, a system with Tg corresponding in the range 
of the unacceptable temperature for product storage was 
designed via the combination of PEG and MC combining a very 
high and a very low Tg. Anthocyanidin and sodium acetate were 
mixed to indicate colour change, the neutral colourless 
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anthocyanidin under action of sodium acetate turned purple 
with increasing temperature of PEG/MC mixture. The active 
part of the particles was the CS/gallotannin-based shell, which 
takes the advantage of antibacterial CS and photoprotective 
and antioxidative gallotannin. The analysis results showed that 
the prepared SANPs turned from colourless to purple at about 
20 °C and 0 °C respectively. Moreover, the SANPs displayed 
effective antibacterial activity, UV light absorption, 
antioxidative activity, and non-toxicity, demonstrating the 
promising application of the prepared polysaccharide-based 
SANPs in the food packaging area. 
The influence of polysaccharide NPs such as CSNPs on the 
improvement of the physical/chemical properties of food 
packaging materials such as mechanical strength and thermal 
stability were investigated by various groups.281, 282 For 
example, the addition polysaccharide NPs enables reduction of 
the water vapour permeability (WVP) of food packaging 
materials, which has attracted frequent attention as it is a vital 
issue for the development of sustainable packaging materials. 
NPs are considered to be suitable for reducing WVP because 
they distort the diffusion pathways for the water vapour 
through the packaging film.283, 284 In the area of mechanical 
improvements, Mattoso and coworkers described the 
fabrication of nanocomposite films of CS NPs in pectin matrix 
(Fig. 15).282 CS NPs were combined with high methyl (HDM) and 
low methyl (LDM) pectin matrices. Next, films were casted that 
showed homogeneous, compact, and continuous properties. 
The addition of CSNPs improved the mechanical properties 
considerably, e.g. tensile strength increased from 30.81 to 
46.95 MPa and from 26.07 to 58.51 MPa for HDM pectin/CSNP 
and LDM pectin/CSNP, respectively. 
 
Fig. 15 Overview of nanocomposite formation from pectin and CS NPs and casted films. 
(Reproduced with permission from 282. Copyright Elsevier, 2016.)  
Sun and coworkers investigated the effects of taro-derived SNPs 
content on the properties of corn starch-based packaging 
films.285 Their work showed that the addition of taro SNPs to the 
corn starch films increased the tensile strength of films from 
1.11 MPa to 2.87 MPa. It was also found that strong interactions 
between taro SNPs and films improved the thermal stability of 
starch films. Moreover, the WVP of the films was decreased 
after addition of taro SNPs, and the degree of the WVP 
reduction correlated with the concentration of the taro SNPs. 
These results demonstrated the potential of incorporating taro 
SNPs into corn starch films for developing biodegradable starch-
based films with improved properties. A similar study was 
conducted by the same group.286 Potato-derived SNPs were 
incorporated into pea starch-based nanocomposite films. The 
mechanical properties of the films were found to be enhanced 
by the addition of potato SNPs, and particularly for the 
incorporation of 6% potato SNPs, the film tensile strength 
increased the most (from 8.8 MPa to 15.0 MPa). Compared to 
control samples, the melting temperature of the 
nanocomposite films increased with the increased potato SNPs 
content. For the WVP and water-solubility of the 
nanocomposite films, the incorporation of 6% potato SNPs led 
to the most significant reduction of the WVP value but it 
increased again with higher content values. The phenomenon 
was assigned to the abundant hydroxyl groups in excessive 
potato SNPs showing more affinity for water than starch. The 
lowest water-solubility of the nanocomposite films was also 
obtained at the potato SNPs content of 6%. The improved 
reduction of water-solubility was considered to be related to 
the high tensile strength values and the entanglement between 
SNPs and starch chains, which decreased the nanocomposites’ 
solubility. The results discussed above proved that adding 
potato SNPs into the pea starch films could be applied in 
developing degradable food packaging, while WVP and water-
solubility can be minimised via the optimisation of material 
composition. 
Polysaccharide NPs play a significant role in developing 
improved food packaging materials. They can combine the 
advantages of both intelligent packaging and active packaging. 
Moreover, issues such as high WVP and limited mechanical 
properties caused by using polysaccharide films can also be 
overcome by the addition of polysaccharide NPs.282, 285, 286  
5.3.2 Polysaccharide NPs for the Delivery of Ingredients in Food 
Many of the common food constituents containing beneficial 
biological activities, such as nutraceuticals, vitamins, and 
nutrients, are highly lipophilic molecules. As such, there are 
various factors limiting the incorporation and delivery of pure 
lipophilic bioactive substances, for instance, chemical 
instability, poor bioavailability, poor water solubility, and the 
interactions between the ingredients. To overcome these 
challenges in the applications of food and nutrition, 
nanotechnological approaches provide a direction for the 
encapsulation and controlled-release of active food ingredients 
(Scheme 9).277, 287-289  
 
Scheme 9 Overview of the design of food ingredient delivery systems to control 
bioavailability via body–particle interactions. (Reproduced with permission from 290. 
Copyright John Wiley and Sons, 2017.) 
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Different examples of suitable nanoscale delivery systems for 
transporting food constituents were listed and discussed in the 
review of McClements,287 such as micelles, 
micro/nanoemulsions, liposomes, microgels, and biopolymer 
NPs (e.g. protein NPs and polysaccharide NPs). For the delivery 
systems based on polysaccharides, their properties such as 
thermal stability, digestibility, and antioxidant capacity, depend 
significantly on the components used to construct a nanoscale 
delivery system.  
Shimoni’s group entrapped a hydrophobic nutraceutical, the 
water-insoluble isoflavone Genistein, into enzymatically 
synthesised DEXNPs.291 The dextransucrase generated spherical 
DEXNPs were prepared under optimised conditions (pH 5.2–6 
and sucrose concentration > 0.5 M). Although the bioavailability 
of the DEXNPs was increased due to the smaller particle size, 
larger surface area, and increased solubility caused by the 
Genistein inclusion, it was found that the loading efficiency of 
Genistein was very low. The limitation in Genistein loading was 
considered to result from the fact that the Genistein was only 
included in dextran particles without forming complexes with 
the dextran chains. The study provided a good guide to develop 
nanosized vehicles to incorporate and stabilise the hydrophobic 
bioactive compounds in foods, which was useful to establish 
more platforms for delivering water insoluble bioactive 
chemicals in food and/or pharmaceuticals. 
Developing delivery systems based on polysaccharide NPs can 
also be combined with the food packaging applications 
mentioned in Section 5.3.1. Nieto-Suaza et al. prepared 
curcumin-loaded SNPs as the reinforcing agent to be 
incorporated into the aloe vera gel-banana starch composite 
films.292 The results obtained from their work showed that the 
addition of curcumin-loaded SNPs could enhance several 
properties of the composite films. For instance, with the 
increased concentration of the curcumin-loaded SNPs, the 
important WVP of the composite films decreased. One reason 
for that phenomenon has been discussed above, which is the 
distortion of the water diffusion path caused by the addition of 
SNPs. Besides, the existence of the hydrophobic curcumin also 
played an important role in reducing WVP because it can limit 
the interaction between water and the polymeric matrix. 
Moreover, it was observed that the antimicrobial and 
antioxidative curcumin could be released from the composite 
films to different food simulants, such as simulate hydrophobic, 
simulate hydrophilic, and simulate lipophilic foods. The 
curcumin release was favoured in simulated lipophilic foods and 
could be controlled by modifying the polarity of the SNPs by 
acetylation. The group’s work combined the effective 
utilisations of polysaccharide NPs in food delivery systems and 
food packaging, indicating the promising future of developing 
biodegradable composite films that can incorporate bioactive 
substances in food industries. 
Furthermore, there are other practical polysaccharide NPs 
related food delivery systems widely used in transporting 
bioactive substances. For example, abundant and antimicrobial 
CSNPs have been widely used as nanocarriers for transporting 
tea polyphenols, which are nutraceuticals bringing multi-health 
benefits including cancer prevention, antioxidant activities, 
antibacterial activities, and immune enhancement. However, 
some associated challenges can be caused by factors such as the 
presence of ions, pH, and enzymes in the gastrointestinal tract. 
The uncontrollable size of CSNPs resulted from fluctuations of 
these factors may affect the stability of the tea polyphenols 
loaded CSNPs.293, 294 Gao and coworkers fabricated zein–
propylene glycol alginate-tea saponin (TS) ternary complex 
nanoparticles for the delivery of Resveratrol.295 The presence of 
TS on the particles significantly improved Resveratrol loading as 
well as the environmental stability of Resveratrol. The best 
release characteristics in the small intestine were obtained for 
a ratio of zein to TS of 4:3 as observed via an in vitro digestion 
model. As such, the novel protein–polysaccharide–surfactant 
ternary complex enabled efficient delivery of resveratrol. 
McClements and coworkers summarised several examples of 
forming protein–polysaccharide NPs based delivery systems by 
conjugating polysaccharide (e.g. CS, DEX) with another common 
biopolymer protein (e.g. Whey Protein Isolate, OVA).290 The 
functional properties of proteins can be improved by 
conjugation to polysaccharides, giving tailored gastrointestinal 
protection and physicochemical stability. However, regulatory 
issues may be caused by using conjugates compared to all-
natural ingredients, and the production costs may increase due 
to the additional ingredients and processing operations 
required to fabricate conjugates.  
NPs based on natural polysaccharides can fulfil most of the 
requirements to be applied in food-grade delivery systems due 
to their biodegradability and biocompatibility. Despite several 
advantages like effective encapsulation of bioactive substances 
and improved stability against enzymes in the gastrointestinal 
tract, drawbacks such as the aggregation of polysaccharide NPs 
and burst release caused by small particle size and large surface 
area need more attention. Therefore, future studies are 
necessary to overcome these challenges and fabricate 
polysaccharide nanocarriers with improved properties for 
delivery systems in food.293, 294 
6. Conclusion and Outlook 
Polysaccharide NPs have found considerable attention in the 
past decade mainly for biomedical applications but also use in 
cosmetics and food has been implemented. The utilised 
polysaccharides are obtained from various natural sources 
making them prime candidates for sustainable nanotechnology. 
Furthermore, polysaccharides have favourable biological 
properties and activities depending on their chemical 
structures. Key features are the remarkable biodegradability, 
biocompatibility, and low-toxicity of polysaccharides that 
support their broad applications in biological environment – a 
key driver for future developments. 
The basis for polysaccharide NPs are the preparation methods. 
A variety of synthesis methods for preparing NPs with 
polysaccharides and their derivatives were presented in here 
highlighting the broad range of options in polysaccharide NP 
synthesis. The choice of a suitable synthesis method depends 
on the specific application and its requirements. For instance, 
to fabricate excellent polysaccharide NPs based nanocarriers 
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for in vivo delivery systems, controllable size, charge, surface 
morphology, loading capacity, and substances release are 
important. These requirements can mostly be satisfied by 
choosing one of the common fabrication methods, e.g. 
nanoprecipitation, complex coacervation, emulsification, or 
other practical methods. However, there are some limitations 
of these methods that have to be taken into account, such as 
the requirement of large amounts of organic solvents for the 
emulsification method and the potential toxicity issue when 
using the desolvation method, for example. Although, the 
fabrication of polysaccharide NPs has been investigated 
thoroughly in recent years, novel approaches are still sought 
after. Especially, the replacement of organic solvents with 
harmless and/or sustainable alternatives could be a 
considerable direction as well as improved control over particle 
size and shape with new template methods. 
A direction in polysaccharide NPs with considerable growth 
potential is the combination with polymeric materials. For 
example, to attach polymers to polysaccharide NPs to form 
polysaccharide/polymer NP systems, “grafting to” and “grafting 
from” reactions are applied. In “grafting to” reactions, 
functionalised and fully characterised polymer is prepared in 
advance before attachment. While in “grafting from” reactions, 
monomers polymerise directly on the interface of 
polysaccharide NPs. After graft modification, polysaccharide-
polymer based core-shell NPs are obtained that feature new 
properties to be tailored via the chemistry of the grafted 
polymer. The inclusion of a polysaccharide NP core into the 
polymer shell can introduce improved stability against solvents 
and stimuli response indicating the potential use of 
polysaccharide-polymer based core-shell NPs in biomedical 
applications. Furthermore, inclusion of polysaccharide NPs into 
polymer materials leads to enhancement of the mechanical 
properties with possible implications for polymer materials 
production on an industrial-scale. The field of 
polysaccharide/polymer hybrid and composite materials is still 
underrepresented in the literature. Nevertheless, various 
directions can be foreseen, for example tailoring of polymer 
surface wettability via polysaccharide NP introduction or 
control of drug release from polysaccharide NPs via responsive 
polymer shells. 
As effective nano-sized carriers, polysaccharide NPs have broad 
applications in transporting substances. When utilised in 
nanomedicine, cosmetics, and food areas, polysaccharide NPs 
introduce various benefits for the transport of drugs, genes and 
other hydrophobic and lipophilic substances via efficient 
protective encapsulation, improving the bioavailability and 
chemical stability of these substances. In nanomedicine, the 
EPR effect allows the targeted delivery of drug/gene-loaded 
polysaccharide NPs to pathological tissues, and various in vitro 
release studies demonstrated that the loaded drugs and genes 
could be released in a controlled and sustained manner. These 
useful results also play a significant role in tissue engineering 
applications which are based on growth factors delivery. 
Moreover, it was proven that polysaccharide NPs could be 
practical for the delivery and controlled-release of cosmetic and 
food ingredients, showing the promising future of 
polysaccharide NPs based nanocarriers. Certainly, in the future 
advanced nanocarriers will be developed that allow more 
targeted delivery as well as tailored release profiles. Here 
functionalisation of polysaccharide NPs with targeting moieties 
and polymers could be an avenue. 
On the other hand, polysaccharide NPs can be designed as 
Pickering emulsion stabilisers and material reinforcing agent in 
cosmetics and food packaging areas due to their environmental-
friendly properties. According to former studies, emulsions 
stabilised by polysaccharide NPs showed their potential to 
produce long-term stabilised formulations in cosmetics. After 
adding polysaccharide NPs to the packaging films, the 
mechanical properties were enhanced accompanied by lower 
WVP values, indicating the potential of incorporating 
polysaccharide NPs into other materials for developing food 
packaging materials with improved properties. Also, in the 
stabilisation of emulsions and introduction in food packaging 
further tailored functionalisation could have a positive effect on 
overall materials properties, e.g. when interaction of 
polysaccharide NPs and matrix materials are improved. 
Overall, it can be concluded that polysaccharide NPs have 
proven to be very important future biological nanocarriers, 
emulsifiers, and material reinforcing additives. However, more 
research is still required to work out issues when fabricating and 
using them. For instance, it is important to promote the 
preclinical results from in vitro cellular studies and in vivo animal 
studies to the human system. Also, aggregation of 
polysaccharide NPs and burst release of substances are worth 
mentioning. Therefore, further deep studies are necessary to 
promote the applications of polysaccharide NPs and ensure 
their safety and efficacy in the future. 
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AFM - Atomic force microscopy 
ATPS - Aqueous two-phase system 
BMP - Bone Morphogenetic Protein 
CA - Cellulose Acetate 
CH - Chitin 
CL - Cellulose 
CLNPs - Cellulose-Based Nanoparticles 
CRG - Carrageenan 
CS - Chitosan 
CSNPs - Chitosan-Based Nanoparticles 
DEX - Dextran 
DEXNPs - Dextran-Based Nanoparticles 
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DDT - Dodecanethiol 
DGNPs - DEX- and Gelatin-Based Nanoparticle System 
DOX - Doxorubicin 
DS - Dextran Sulfate  
EPR - Enhanced Permeation and Retention 
FAM - Fluorescein amidite 
HA - Hyaluronic Acid 
HANPs - Hyaluronic Acid-Based Nanoparticles 
HDM - High methyl pectin matrix 
HRA NPs – NPs formed by coupling HA with aminated retinoid 
acid (ATRA) 
HUVEC - Human umbilical vein endothelial cell 
LDM - Low methyl pectin matrix 
MC – Methylcellulose 
MFI - Mean fluorescence intensity 
MTX – Methotrexate 
MMP9 - Metalloproteinase 9 
MW – Molecular Weight 
MXS - Minoxidil Sulphate 
NP - Nanoparticle 
OCMCS - Oleoyl-Carboxymethyl-Chitosan 
OVA - Ovalbumin 
O/W - Oil-in-Water 
PBAE - Poly(β-amino) ester 
PCS-5 - HIV protease cleavage site 5 peptide 
PDGF-BB - Platelet Derived Growth Factor 
pDNA - plasmid DNA 
PEA - Poly(ethyl acrylate) 
PEI - Poly(ethylene imine) 
PEG – Poly(ethylene glycol) 
PEGDA- Poly(ethylene glycol) diacrylate 
pEGFP - Plasmid DNA expressing green fluorescent protein 
pep - MMP9 cleavable connection 
PFP - Perfluoropentane 
Poly(I:C) – poly(inosinic acid):poly(cytidylic acid) 
PLA – Polylactide 
PLGA - Poly(D, L-lactide-co-glycolide) 
PMA - Poly(methyl acrylate) 
PMMA - Poly(methyl methacrylate) 
PMMA-b-P(PEGMA) - Poly(methyl methacrylate)-b-
poly(poly(ethylene glycol) methyl ether methacrylate) 
P(MMA-co-S) - Poly(methyl methacrylate-co-styrene) 
PNIPAM - Poly(N-isopropylacrylamide) 
PPC - Poly(propylene carbonate) 
P(PEGMA) - Poly(poly(ethylene glycol) methyl ether 
methacrylate) 
PTX - Paclitaxel 
SANPs - Smart and Active Nanoparticles 
SEM - Scanning Electron Microscopy 
SG1 - N-tert-butyl-N-[1-diethylphosphono-(2,2-dimethylpropyl) 
nitroxide] 
siRNA – small interfering RNA 
SI-SET-LRP - Surface-Initiated Single-Electron Transfer Living 
Radical Polymerisation 
SNPs - Starch-Based Nanoparticles 
TEM - Transmission Electron Microscopy 
Tg - Glass Transition Temperature 
THF - Tetrahydrofuran 
TPP – Tripolyphosphate 
TS – Tea saponin 
VBC - 4-Vinylbenzyl Chloride 
VEGF - Vascular Endothelial Growth Factor 
W/O - Water-in-Oil 
W/W - Water-in-Water 
WVP - Water Vapour Permeability 
5-FU - 5-Fluorouracil 
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